| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.38e-09 | 4 | 141 | 4 | GO:0004971 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 5.28e-06 | 17 | 141 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK8 UAP1 MAP4K3 POLA1 RPS6KB2 NRG2 DGKQ CDK14 NUAK2 PARP1 MB21D2 GRK2 CLK1 BRD4 MASTL PEAK1 MAP2K6 UAP1L1 MUSK REV1 | 9.84e-06 | 938 | 141 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.27e-05 | 24 | 141 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | histone reader activity | 3.16e-05 | 26 | 141 | 4 | GO:0140566 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.69e-05 | 27 | 141 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine diphosphorylase activity | 4.95e-05 | 2 | 141 | 2 | GO:0003977 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.10e-05 | 57 | 141 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 6.54e-05 | 60 | 141 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 9.61e-05 | 65 | 141 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 9.61e-05 | 65 | 141 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 EP400 ATAD5 KIF26B ABCC9 CHD3 DNAH17 DDX54 ERCC6L2 MACF1 ATP2A1 TOP2A TOP2B KIF22 | 1.16e-04 | 614 | 141 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.90e-04 | 75 | 141 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 1.97e-04 | 41 | 141 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.15e-04 | 77 | 141 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR TCF4 EP400 POLA1 CHD3 EZH1 MECP2 PARP1 H1-8 SF3B1 BRD4 NUCKS1 DLX3 TOP2A TOP2B | 2.35e-04 | 739 | 141 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.60e-04 | 44 | 141 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.86e-04 | 127 | 141 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 2.94e-04 | 4 | 141 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDK8 MAP4K3 RPS6KB2 NRG2 CDK14 NUAK2 GRK2 CLK1 BRD4 MASTL PEAK1 MAP2K6 MUSK | 3.36e-04 | 600 | 141 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK8 MAP4K3 RPS6KB2 NRG2 DGKQ CDK14 NUAK2 GRK2 CLK1 BRD4 MASTL PEAK1 MAP2K6 MUSK | 5.03e-04 | 709 | 141 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | scaffold protein binding | 5.16e-04 | 93 | 141 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.57e-04 | 262 | 141 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 7.19e-04 | 100 | 141 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 7.43e-04 | 152 | 141 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 8.97e-04 | 105 | 141 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 1.02e-03 | 7 | 141 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | kinase activity | CDK8 MAP4K3 RPS6KB2 NRG2 DGKQ CDK14 NUAK2 GRK2 CLK1 BRD4 MASTL PEAK1 MAP2K6 MUSK | 1.04e-03 | 764 | 141 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.23e-03 | 229 | 141 | 7 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.28e-03 | 446 | 141 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.35e-03 | 8 | 141 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 1.35e-03 | 8 | 141 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.37e-03 | 68 | 141 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.44e-03 | 69 | 141 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.60e-03 | 71 | 141 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.07e-03 | 36 | 141 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 2.15e-03 | 10 | 141 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.15e-03 | 10 | 141 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | TCF4 SSX8P EZH1 MECP2 ZFPM2 KMT2C BRD4 DDX54 NUCKS1 INSM2 TAF15 | 2.17e-03 | 562 | 141 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.25e-03 | 37 | 141 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.51e-03 | 193 | 141 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.78e-03 | 197 | 141 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein kinase binding | SLC12A6 TPR POLA1 GRIA1 GRIA2 CEP192 POTEKP DNAJA3 PARP1 CD4 ERCC6L2 MAP2K6 MUSK TOP2A | 3.55e-03 | 873 | 141 | 14 | GO:0019901 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.55e-03 | 207 | 141 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | kinase binding | SLC12A6 TPR POLA1 DGKQ GRIA1 GRIA2 CEP192 POTEKP DNAJA3 PARP1 CD4 ERCC6L2 MAP2K6 MUSK TOP2A | 3.56e-03 | 969 | 141 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.64e-03 | 208 | 141 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.70e-03 | 145 | 141 | 5 | GO:0004713 | |
| GeneOntologyBiologicalProcess | DNA damage response | REXO4 EP400 DCUN1D5 ATAD5 POLA1 TRAIP HUWE1 ZNF365 USP44 PARP1 BRD4 MDC1 ERCC6L2 MASTL NUCKS1 MAP2K6 TOP2A TOP2B KIF22 REV1 | 6.82e-06 | 959 | 139 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 3.07e-05 | 27 | 139 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 4.51e-05 | 2 | 139 | 2 | GO:0045870 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 4.36e-05 | 30 | 138 | 4 | GO:0032281 | |
| GeneOntologyCellularComponent | chromatin | TCF4 EP400 POLA1 ICE2 AHCTF1 HLF CHD3 POTEKP DBP EZH1 MECP2 ZEB2 ZFPM2 USP44 PARP1 H1-8 SF3B1 BRD4 NUCKS1 DLX3 DLX5 TOP2B KIF22 | 1.02e-04 | 1480 | 138 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.20e-04 | 45 | 138 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | perisynaptic space | 2.57e-04 | 4 | 138 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | nuclear body | REXO4 EP400 ICE2 CARMIL1 AHCTF1 DGKQ MECOM CHD3 PRX PARP1 SF3B1 UBN1 SETBP1 MDC1 USP15 KIF22 | 3.11e-04 | 903 | 138 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 3.31e-04 | 50 | 138 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 7.09e-04 | 61 | 138 | 4 | GO:0000307 | |
| MousePheno | increased muscle fatigability | 8.40e-06 | 16 | 119 | 4 | MP:0003646 | |
| MousePheno | decreased chemical nociceptive threshold | 3.27e-05 | 8 | 119 | 3 | MP:0008532 | |
| Domain | AT_hook | 4.44e-06 | 16 | 135 | 4 | PF02178 | |
| Domain | Lig_chan-Glu_bd | 7.38e-06 | 18 | 135 | 4 | PF10613 | |
| Domain | Glu/Gly-bd | 7.38e-06 | 18 | 135 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 7.38e-06 | 18 | 135 | 4 | SM00918 | |
| Domain | Iontro_rcpt | 7.38e-06 | 18 | 135 | 4 | IPR001320 | |
| Domain | Iono_rcpt_met | 7.38e-06 | 18 | 135 | 4 | IPR001508 | |
| Domain | Lig_chan | 7.38e-06 | 18 | 135 | 4 | PF00060 | |
| Domain | PBPe | 7.38e-06 | 18 | 135 | 4 | SM00079 | |
| Domain | AT_hook | 4.03e-05 | 27 | 135 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.03e-05 | 27 | 135 | 4 | IPR017956 | |
| Domain | - | 5.19e-05 | 2 | 135 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 5.19e-05 | 2 | 135 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 5.19e-05 | 2 | 135 | 2 | PF00204 | |
| Domain | - | 5.19e-05 | 2 | 135 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 5.19e-05 | 2 | 135 | 2 | IPR018522 | |
| Domain | DUF4414 | 5.19e-05 | 2 | 135 | 2 | PF14377 | |
| Domain | Topo_IIA | 5.19e-05 | 2 | 135 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 5.19e-05 | 2 | 135 | 2 | PF00521 | |
| Domain | DUF4414 | 5.19e-05 | 2 | 135 | 2 | IPR025527 | |
| Domain | Topo_IIA_A/C_ab | 5.19e-05 | 2 | 135 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 5.19e-05 | 2 | 135 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 5.19e-05 | 2 | 135 | 2 | IPR013759 | |
| Domain | TOP4c | 5.19e-05 | 2 | 135 | 2 | SM00434 | |
| Domain | TOP2c | 5.19e-05 | 2 | 135 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 5.19e-05 | 2 | 135 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 5.19e-05 | 2 | 135 | 2 | IPR013506 | |
| Domain | DTHCT | 5.19e-05 | 2 | 135 | 2 | PF08070 | |
| Domain | - | 5.19e-05 | 2 | 135 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 5.19e-05 | 2 | 135 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 5.19e-05 | 2 | 135 | 2 | PF16898 | |
| Domain | Topo_IIA_A/C | 5.19e-05 | 2 | 135 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 5.19e-05 | 2 | 135 | 2 | PS00177 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.06e-05 | 31 | 135 | 4 | IPR000637 | |
| Domain | ANF_lig-bd_rcpt | 1.43e-04 | 37 | 135 | 4 | IPR001828 | |
| Domain | ANF_receptor | 1.43e-04 | 37 | 135 | 4 | PF01094 | |
| Domain | Distal-less_N | 1.55e-04 | 3 | 135 | 2 | IPR022135 | |
| Domain | UDPGP | 1.55e-04 | 3 | 135 | 2 | PF01704 | |
| Domain | Arg_repress_C-like | 1.55e-04 | 3 | 135 | 2 | IPR024946 | |
| Domain | DLL_N | 1.55e-04 | 3 | 135 | 2 | PF12413 | |
| Domain | TACC | 1.55e-04 | 3 | 135 | 2 | PF05010 | |
| Domain | - | 1.55e-04 | 3 | 135 | 2 | 3.30.1360.40 | |
| Domain | UDPGP_fam | 1.55e-04 | 3 | 135 | 2 | IPR002618 | |
| Domain | TACC | 1.55e-04 | 3 | 135 | 2 | IPR007707 | |
| Domain | Peripla_BP_I | 1.76e-04 | 39 | 135 | 4 | IPR028082 | |
| Domain | S_TKc | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL PEAK1 MAP2K6 | 2.85e-04 | 359 | 135 | 10 | SM00220 |
| Domain | Toprim | 3.08e-04 | 4 | 135 | 2 | PF01751 | |
| Domain | Toprim_domain | 3.08e-04 | 4 | 135 | 2 | IPR006171 | |
| Domain | TOPRIM | 3.08e-04 | 4 | 135 | 2 | PS50880 | |
| Domain | BRCT | 3.29e-04 | 19 | 135 | 3 | PF00533 | |
| Domain | Pkinase | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL PEAK1 MAP2K6 | 4.56e-04 | 381 | 135 | 10 | PF00069 |
| Domain | PROTEIN_KINASE_ATP | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL PEAK1 MAP2K6 MUSK | 5.09e-04 | 459 | 135 | 11 | PS00107 |
| Domain | BRCT | 5.14e-04 | 22 | 135 | 3 | SM00292 | |
| Domain | Kinase-like_dom | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL MACF1 PEAK1 MAP2K6 MUSK | 5.74e-04 | 542 | 135 | 12 | IPR011009 |
| Domain | - | 5.88e-04 | 23 | 135 | 3 | 3.40.50.10190 | |
| Domain | PH_12 | 7.63e-04 | 6 | 135 | 2 | PF16457 | |
| Domain | BRCT | 8.50e-04 | 26 | 135 | 3 | PS50172 | |
| Domain | Prot_kinase_dom | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL PEAK1 MAP2K6 MUSK | 8.57e-04 | 489 | 135 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK8 MAP4K3 RPS6KB2 CDK14 NUAK2 GRK2 CLK1 MASTL PEAK1 MAP2K6 MUSK | 9.16e-04 | 493 | 135 | 11 | PS50011 |
| Domain | BRCT_dom | 1.06e-03 | 28 | 135 | 3 | IPR001357 | |
| Domain | PH_dom-like | AGAP5 RGPD8 EPB41L4B DOCK9 GRK2 PLCH2 PLCL1 AGAP9 FGD6 RGPD5 | 1.07e-03 | 426 | 135 | 10 | IPR011993 |
| Domain | Ser/Thr_kinase_AS | 1.17e-03 | 357 | 135 | 9 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 1.28e-03 | 362 | 135 | 9 | PS00108 | |
| Domain | SNF2_N | 1.57e-03 | 32 | 135 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.57e-03 | 32 | 135 | 3 | PF00176 | |
| Domain | Protein_kinase_ATP_BS | 1.76e-03 | 379 | 135 | 9 | IPR017441 | |
| Domain | BPI1 | 1.81e-03 | 9 | 135 | 2 | SM00328 | |
| Domain | BPI2 | 1.81e-03 | 9 | 135 | 2 | SM00329 | |
| Domain | LBP_BPI_CETP | 1.81e-03 | 9 | 135 | 2 | PS00400 | |
| Domain | Ribosomal_S5_D2-typ_fold | 1.88e-03 | 34 | 135 | 3 | IPR020568 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.04e-03 | 35 | 135 | 3 | IPR002464 | |
| Domain | - | 2.17e-03 | 391 | 135 | 9 | 2.30.29.30 | |
| Domain | LBP_BPI_CETP_C | 2.25e-03 | 10 | 135 | 2 | PF02886 | |
| Domain | DEAH_ATP_HELICASE | 2.59e-03 | 38 | 135 | 3 | PS00690 | |
| Domain | Grip | 2.73e-03 | 11 | 135 | 2 | SM00755 | |
| Domain | GRIP | 2.73e-03 | 11 | 135 | 2 | PF01465 | |
| Domain | Ran_BP1 | 3.26e-03 | 12 | 135 | 2 | PF00638 | |
| Domain | RANBD1 | 3.26e-03 | 12 | 135 | 2 | PS50196 | |
| Domain | GRIP_dom | 3.26e-03 | 12 | 135 | 2 | IPR000237 | |
| Domain | GRIP | 3.26e-03 | 12 | 135 | 2 | PS50913 | |
| Domain | Lipid-bd_serum_glycop_C | 3.26e-03 | 12 | 135 | 2 | IPR001124 | |
| Domain | LBP_BPI_CETP | 3.84e-03 | 13 | 135 | 2 | PF01273 | |
| Domain | RanBD | 3.84e-03 | 13 | 135 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 3.84e-03 | 13 | 135 | 2 | IPR000156 | |
| Domain | BPI/LBP/Plunc | 3.84e-03 | 13 | 135 | 2 | IPR032942 | |
| Domain | Bactericidal_perm-incr_a/b_dom | 3.84e-03 | 13 | 135 | 2 | IPR017943 | |
| Domain | Lipid-bd_serum_glycop_N | 3.84e-03 | 13 | 135 | 2 | IPR017942 | |
| Domain | PH | 4.12e-03 | 278 | 135 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 4.21e-03 | 279 | 135 | 7 | PS50003 | |
| Domain | PH_domain | 4.29e-03 | 280 | 135 | 7 | IPR001849 | |
| Domain | EF-hand_like | 5.12e-03 | 15 | 135 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 5.12e-03 | 15 | 135 | 2 | PF00387 | |
| Domain | PLCYc | 5.12e-03 | 15 | 135 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 5.12e-03 | 15 | 135 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 5.12e-03 | 15 | 135 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 5.12e-03 | 15 | 135 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 5.12e-03 | 15 | 135 | 2 | IPR015359 | |
| Domain | bZIP_2 | 6.57e-03 | 17 | 135 | 2 | PF07716 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 5.13e-06 | 16 | 106 | 4 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 6.67e-06 | 17 | 106 | 4 | M5488 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 8.52e-06 | 18 | 106 | 4 | M48098 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.64e-05 | 21 | 106 | 4 | M838 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.99e-05 | 22 | 106 | 4 | M39795 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.99e-05 | 22 | 106 | 4 | MM15104 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 6.21e-05 | 29 | 106 | 4 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 8.13e-05 | 31 | 106 | 4 | M7223 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.32e-04 | 35 | 106 | 4 | MM15109 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 2.19e-04 | 73 | 106 | 5 | M39401 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 2.47e-04 | 41 | 106 | 4 | M39655 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 4.29e-04 | 20 | 106 | 3 | MM15485 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NOL4 REXO4 DCUN1D5 ATAD5 POLA1 AHCTF1 WDR70 CHD3 MECP2 ZEB2 PARP1 UBN1 BRD4 MDC1 DDX54 MASTL TOP2A TOP2B KIF22 | 7.64e-12 | 608 | 142 | 19 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | TPR REXO4 EP400 AHCTF1 WDR70 CHD3 MECP2 PARP1 SF3B1 BRD4 MDC1 TAF15 TOP2A TOP2B | 1.28e-11 | 283 | 142 | 14 | 30585729 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR EP400 TCOF1 ATAD5 CARMIL1 AHCTF1 WDR70 RPS20 CHD3 TACC2 ME2 PARP1 SF3B1 AHNAK MASTL NUCKS1 MACF1 TAF15 CAMSAP1 TOP2A TOP2B AHNAK2 | 3.67e-11 | 934 | 142 | 22 | 33916271 |
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 2.66e-10 | 4 | 142 | 4 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 2.66e-10 | 4 | 142 | 4 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 2.66e-10 | 4 | 142 | 4 | 17828255 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 24652293 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 2.66e-10 | 4 | 142 | 4 | 12692557 | |
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 12125045 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 10688364 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 17409242 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 14561864 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 1319477 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 9648857 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ABCC1 EP400 TCOF1 ATAD5 AHCTF1 MECOM RPS20 CHD3 MECP2 ZSCAN29 DNAJA3 KMT2C PARP1 SF3B1 UBN1 CCNB2 AHNAK BRD4 MDC1 DDX54 TAF15 TOP2A TOP2B KIF22 | 5.58e-10 | 1294 | 142 | 24 | 30804502 |
| Pubmed | 6.08e-10 | 72 | 142 | 8 | 31248990 | ||
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 16129400 | ||
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 9482932 | ||
| Pubmed | ABCC1 RGPD8 EP400 DCUN1D5 ICE2 SYTL2 WDR70 MECOM HUWE1 NBAS MDC1 EIF2S2 MASTL NUCKS1 SECISBP2 SCPEP1 CAMSAP1 USP15 | 1.34e-09 | 733 | 142 | 18 | 34672954 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TPR EP400 TCOF1 AHCTF1 CHD3 POTEKP PARP1 SF3B1 AHNAK MDC1 TOP2A TOP2B | 1.39e-09 | 271 | 142 | 12 | 32433965 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR REXO4 EP400 ATAD5 AHCTF1 CASP8 RPS20 CHD3 MECP2 PARP1 SF3B1 UBN1 AHNAK BRD4 MDC1 EIF2S2 TAF15 ATP2A1 TOP2A TOP2B | 2.29e-09 | 954 | 142 | 20 | 36373674 |
| Pubmed | TPR RGPD8 PARP1 SF3B1 AHNAK MDC1 DDX54 MACF1 CAMSAP1 TOP2A TOP2B | 3.72e-09 | 234 | 142 | 11 | 36243803 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR REXO4 FN1 EP400 MAP4K3 POLA1 AHCTF1 WDR70 CASP8 RPS20 HUWE1 DNAJA3 PARP1 SF3B1 UBN1 AHNAK MDC1 EIF2S2 DDX54 MACF1 TOP2A TOP2B AHNAK2 | 6.88e-09 | 1353 | 142 | 23 | 29467282 |
| Pubmed | 9.23e-09 | 7 | 142 | 4 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 9.23e-09 | 7 | 142 | 4 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 9.23e-09 | 7 | 142 | 4 | 9016303 | |
| Pubmed | 9.23e-09 | 7 | 142 | 4 | 27076426 | ||
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 9.23e-09 | 7 | 142 | 4 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 9.23e-09 | 7 | 142 | 4 | 9651535 | |
| Pubmed | AHCTF1 CHD3 HUWE1 PARP1 GRK2 UBN1 AHNAK MACF1 TACC3 CAMSAP1 TOP2A AHNAK2 | 1.35e-08 | 332 | 142 | 12 | 37433992 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR TCF4 EP400 DCUN1D5 WDR70 MECOM QRICH1 HUWE1 MECP2 ZEB2 DARS2 SF3B1 EIF2S2 DLX5 CAMSAP1 TOP2A TOP2B KIF22 | 1.51e-08 | 857 | 142 | 18 | 25609649 |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 1.84e-08 | 8 | 142 | 4 | 23217150 | |
| Pubmed | 3.30e-08 | 9 | 142 | 4 | 24292102 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 3.30e-08 | 9 | 142 | 4 | 9051806 | |
| Pubmed | 3.86e-08 | 121 | 142 | 8 | 22412018 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EP400 ICE2 WDR70 TACC2 QRICH1 PARP1 SF3B1 UBN1 AHNAK MASTL TOP2A TOP2B AHNAK2 | 3.94e-08 | 444 | 142 | 13 | 34795231 |
| Pubmed | TPR EP400 TCOF1 AHCTF1 HUWE1 KMT2C AHNAK BRD4 MDC1 PEAK1 TACC3 USP15 TOP2A RGPD5 | 6.40e-08 | 549 | 142 | 14 | 38280479 | |
| Pubmed | AMPA receptor anchoring at CA1 synapses is determined by N-terminal domain and TARP γ8 interactions. | 6.66e-08 | 3 | 142 | 3 | 34426577 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 15144856 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 18163426 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 12700243 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 12172541 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 21940993 | ||
| Pubmed | Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | 6.66e-08 | 3 | 142 | 3 | 22122651 | |
| Pubmed | Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting. | 6.66e-08 | 3 | 142 | 3 | 28630296 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 36070750 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 22094384 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 32569783 | ||
| Pubmed | Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex. | 6.66e-08 | 3 | 142 | 3 | 36223737 | |
| Pubmed | Persistent synaptic scaling independent of AMPA receptor subunit composition. | 6.66e-08 | 3 | 142 | 3 | 23864664 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 22057216 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 15145077 | ||
| Pubmed | Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. | 6.66e-08 | 3 | 142 | 3 | 28290985 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 26585043 | ||
| Pubmed | Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. | 6.66e-08 | 3 | 142 | 3 | 14687553 | |
| Pubmed | Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2. | 6.66e-08 | 3 | 142 | 3 | 29180434 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 19217372 | ||
| Pubmed | Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. | 6.66e-08 | 3 | 142 | 3 | 19409270 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 21135237 | ||
| Pubmed | LTP requires a reserve pool of glutamate receptors independent of subunit type. | 6.66e-08 | 3 | 142 | 3 | 23235828 | |
| Pubmed | EP400 AHCTF1 CHD3 HUWE1 EZH1 MECP2 ZEB2 ZFPM2 KMT2C AHNAK BRD4 TOP2A TOP2B | 7.43e-08 | 469 | 142 | 13 | 27634302 | |
| Pubmed | 1.29e-07 | 12 | 142 | 4 | 11891216 | ||
| Pubmed | REXO4 FN1 EP400 TCOF1 EPB41L4B CEP192 HUWE1 SF3B1 MTFR1 AHNAK INSM2 TAF15 PEAK1 TACC3 CAMSAP1 GGA1 | 1.32e-07 | 777 | 142 | 16 | 35844135 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR EP400 POLA1 CHD3 HUWE1 PARP1 SF3B1 AHNAK MDC1 TOP2A AHNAK2 | 1.33e-07 | 332 | 142 | 11 | 32786267 |
| Pubmed | CDK8 NOL4 EP400P1 EP400 TCOF1 ATAD5 AHCTF1 MECOM CHD3 EZH1 MECP2 DNAJA3 ZNF771 BRD4 SSX2IP FECH MACF1 TOP2A WDR72 | 1.57e-07 | 1116 | 142 | 19 | 31753913 | |
| Pubmed | TPR AHCTF1 RPS20 PARP1 SF3B1 AHNAK MDC1 DDX54 TAF15 TOP2A TOP2B | 1.69e-07 | 340 | 142 | 11 | 29478914 | |
| Pubmed | 1.85e-07 | 13 | 142 | 4 | 25218043 | ||
| Pubmed | TPR EP400 ATAD5 POLA1 WDR70 CHD3 QRICH1 PARP1 SF3B1 UBN1 AHNAK BRD4 MDC1 EIF2S2 NUCKS1 TAF15 TOP2A TOP2B | 1.87e-07 | 1014 | 142 | 18 | 32416067 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR REXO4 TCOF1 ATAD5 MECOM RPS20 CHD3 PARP1 SF3B1 MDC1 DDX54 TAF15 TOP2A TOP2B | 2.09e-07 | 605 | 142 | 14 | 28977666 |
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 28608780 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 2.66e-07 | 4 | 142 | 3 | 10027300 | |
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 23664612 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 30931998 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 29581259 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 12414093 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 26932439 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 31231192 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 31992779 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 29915039 | ||
| Pubmed | Long-term potentiation is independent of the C-tail of the GluA1 AMPA receptor subunit. | 2.66e-07 | 4 | 142 | 3 | 32831170 | |
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 2.66e-07 | 4 | 142 | 3 | 29515177 | |
| Pubmed | AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. | 2.66e-07 | 4 | 142 | 3 | 19004011 | |
| Pubmed | 3.51e-07 | 15 | 142 | 4 | 9481670 | ||
| Pubmed | SLC12A6 RPGRIP1 C8orf88 RGPD8 GRIA1 GRIA2 GRIA3 GRIA4 CHD3 MECP2 ZEB2 PRX PARP1 SF3B1 AHNAK MACF1 TAF15 ATP2A1 TOP2A TOP2B RGPD5 | 4.37e-07 | 1442 | 142 | 21 | 35575683 | |
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 4.67e-07 | 16 | 142 | 4 | 16055064 | |
| Pubmed | TPR FN1 EPB41L4B MAP4K3 DOCK9 AHCTF1 CHD3 TACC2 CEP192 HUWE1 ME2 TRIM59 KMT2C AREL1 FECH MASTL MACF1 PEAK1 | 4.92e-07 | 1084 | 142 | 18 | 11544199 | |
| Pubmed | TPR REXO4 FN1 TCOF1 POLA1 AHCTF1 HUWE1 ME2 SF3B1 AHNAK MDC1 DDX54 MACF1 TAF15 | 5.20e-07 | 653 | 142 | 14 | 22586326 | |
| Pubmed | Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission. | 6.62e-07 | 5 | 142 | 3 | 31492534 | |
| Pubmed | RNF220 is an E3 ubiquitin ligase for AMPA receptors to regulate synaptic transmission. | 6.62e-07 | 5 | 142 | 3 | 36179027 | |
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 6.62e-07 | 5 | 142 | 3 | 1717158 | |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 15797551 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR EP400 TCOF1 CARMIL1 CHD3 HUWE1 MECP2 SF3B1 UBN1 BRD4 MDC1 NUCKS1 TACC3 TOP2A TOP2B | 7.12e-07 | 774 | 142 | 15 | 15302935 |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 7.80e-07 | 18 | 142 | 4 | 18311135 | |
| Pubmed | 8.17e-07 | 245 | 142 | 9 | 21182205 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | NIBAN1 WDR70 MECOM QRICH1 HUWE1 DNAJA3 PARP1 EIF2S2 MASTL TOP2A TOP2B | 8.42e-07 | 400 | 142 | 11 | 35013556 |
| Pubmed | FN1 SYTL2 CHD3 QRICH1 HUWE1 ZEB2 DNAJA3 SF3B1 BRD4 SECISBP2 MACF1 CAMSAP1 GGA1 | 1.02e-06 | 591 | 142 | 13 | 15231748 | |
| Pubmed | 1.13e-06 | 45 | 142 | 5 | 25979088 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.17e-06 | 256 | 142 | 9 | 33397691 | |
| Pubmed | TPR NOL4 RGPD8 MECOM CHD3 HUWE1 ZEB2 AHNAK BRD4 TACC3 CAMSAP1 | 1.29e-06 | 418 | 142 | 11 | 34709266 | |
| Pubmed | Bromodomain Protein BRD4 Is Essential for Hair Cell Function and Survival. | 1.32e-06 | 6 | 142 | 3 | 33015071 | |
| Interaction | PARP1 interactions | CDK8 TCF4 NIBAN1 REXO4 FN1 EP400 ATAD5 POLA1 TRAIP WDR70 CASP8 MECOM GRIA1 CHD3 QRICH1 HUWE1 ZNF365 MECP2 DNAJA3 PARP1 BRD4 EIF2S2 DDX54 MASTL NUCKS1 DLX5 USP15 TOP2A TOP2B KIF22 | 5.92e-09 | 1316 | 140 | 30 | int:PARP1 |
| Interaction | H3-3A interactions | NOL4 REXO4 DCUN1D5 ATAD5 POLA1 AHCTF1 WDR70 CHD3 MECP2 ZEB2 KMT2C PARP1 CD4 SF3B1 UBN1 BRD4 MDC1 MASTL USP15 TOP2A TOP2B KIF22 | 1.05e-08 | 749 | 140 | 22 | int:H3-3A |
| Interaction | SRSF1 interactions | REXO4 FN1 EPB41L4B RPS6KB2 MECOM CHD3 HUWE1 CXCL1 MECP2 SF3B1 CLK1 BRD4 MDC1 DDX54 NUCKS1 TAF15 USP15 TOP2A TOP2B | 1.60e-08 | 570 | 140 | 19 | int:SRSF1 |
| Interaction | CBX3 interactions | CDK8 REXO4 FN1 EP400 TCOF1 ATAD5 AHCTF1 WDR70 MECOM CHD3 EZH1 MECP2 PARP1 BRD4 MDC1 MASTL NUCKS1 MACF1 TOP2A TOP2B | 2.22e-08 | 646 | 140 | 20 | int:CBX3 |
| Interaction | NPM1 interactions | TPR ABCC1 NIBAN1 REXO4 FN1 AHCTF1 RPS6KB2 GRIA2 RPS20 CHD3 HUWE1 MECP2 ZNF771 PARP1 CD4 GPC3 CLK1 BRD4 EIF2S2 DDX54 USP15 GGA1 FGD6 TOP2A TOP2B KIF22 AHNAK2 | 5.24e-08 | 1201 | 140 | 27 | int:NPM1 |
| Interaction | H3C1 interactions | TPR REXO4 ATAD5 POLA1 AHCTF1 MECOM CHD3 MECP2 KMT2C PARP1 SF3B1 UBN1 AHNAK BRD4 MDC1 DDX54 NUCKS1 TAF15 CAMSAP1 TOP2A TOP2B JHY KIF22 | 6.23e-08 | 901 | 140 | 23 | int:H3C1 |
| Interaction | SNRNP40 interactions | REXO4 EP400 TCOF1 ATAD5 POLA1 AHCTF1 CHD3 QRICH1 MECP2 GPBP1L1 SF3B1 UBN1 BRD4 MDC1 MASTL TAF15 USP15 TOP2A TOP2B | 9.26e-08 | 637 | 140 | 19 | int:SNRNP40 |
| Interaction | MRE11 interactions | TPR POLA1 MECOM RPS20 CHD3 HUWE1 ZNF365 PARP1 BRD4 MDC1 NUCKS1 TACC3 TOP2A | 1.08e-07 | 287 | 140 | 13 | int:MRE11 |
| Interaction | XRCC5 interactions | TPR TCF4 FN1 POLA1 RPS6KB2 MECOM CHD3 HUWE1 MECP2 PARP1 BRD4 MDC1 EIF2S2 NUCKS1 PEAK1 TOP2A TOP2B | 1.12e-07 | 515 | 140 | 17 | int:XRCC5 |
| Interaction | NAA40 interactions | TPR EP400 TCOF1 ATAD5 CARMIL1 AHCTF1 WDR70 RPS20 CHD3 TACC2 ME2 MECP2 PARP1 SF3B1 AHNAK MASTL NUCKS1 MACF1 TAF15 CAMSAP1 TOP2A TOP2B AHNAK2 | 2.70e-07 | 978 | 140 | 23 | int:NAA40 |
| Interaction | USP7 interactions | CDK8 TPR RGPD8 POLA1 TRAIP RPS6KB2 CASP8 MECOM GRIA3 HUWE1 MECP2 NUAK2 USP44 DNAJA3 PARP1 SF3B1 UBN1 AHNAK BRD4 MDC1 DDX54 MACF1 CAMSAP1 USP15 TOP2A TOP2B TTLL13 | 3.15e-07 | 1313 | 140 | 27 | int:USP7 |
| Interaction | H3C3 interactions | NOL4 REXO4 DCUN1D5 ATAD5 AHCTF1 WDR70 CHD3 MECP2 ZEB2 PARP1 BRD4 MDC1 DDX54 TOP2A TOP2B KIF22 | 3.59e-07 | 495 | 140 | 16 | int:H3C3 |
| Interaction | PIAS4 interactions | 3.67e-07 | 173 | 140 | 10 | int:PIAS4 | |
| Interaction | SMARCB1 interactions | CDK8 CHD3 TACC2 MECP2 DNAJA3 KMT2C PARP1 UBN1 BRD4 MDC1 NUCKS1 TOP2B KIF22 | 1.60e-06 | 364 | 140 | 13 | int:SMARCB1 |
| Interaction | BAZ1B interactions | 1.66e-06 | 204 | 140 | 10 | int:BAZ1B | |
| Interaction | MCM2 interactions | TPR FN1 RGPD8 EP400 POLA1 TRAIP RPS20 CHD3 HUWE1 ME2 PARP1 SF3B1 UBN1 HMCN1 CCNB2 AHNAK BRD4 MACF1 TAF15 USP15 GGA1 RGPD5 | 5.42e-06 | 1081 | 140 | 22 | int:MCM2 |
| Interaction | SMARCC2 interactions | CDK8 TCF4 MECOM CHD3 MECP2 PARP1 UBN1 BRD4 MDC1 TAF15 USP15 TOP2B | 6.77e-06 | 353 | 140 | 12 | int:SMARCC2 |
| Interaction | H2BC21 interactions | EP400 ATAD5 AHCTF1 HUWE1 CDK14 MECP2 ZSCAN29 PARP1 AHNAK BRD4 MDC1 NUCKS1 TAF15 USP15 TOP2A TOP2B KIF22 | 6.92e-06 | 696 | 140 | 17 | int:H2BC21 |
| Interaction | RPS19 interactions | TPR REXO4 FN1 EPB41L4B RPS6KB2 MECOM RPS20 CHD3 HUWE1 MECP2 CD4 SF3B1 BRD4 EIF2S2 DDX54 USP15 | 9.67e-06 | 639 | 140 | 16 | int:RPS19 |
| Interaction | RPL27 interactions | TCOF1 RPS6KB2 RPS20 CHD3 HUWE1 MECP2 PARP1 H1-8 SF3B1 AHNAK BRD4 TOP2A TOP2B | 1.00e-05 | 431 | 140 | 13 | int:RPL27 |
| Interaction | RPL3 interactions | REXO4 FN1 DCUN1D5 EPB41L4B RPS6KB2 RPS20 CHD3 HUWE1 MECP2 ZNF771 PARP1 H1-8 SF3B1 BRD4 DDX54 TOP2A AHNAK2 | 1.12e-05 | 722 | 140 | 17 | int:RPL3 |
| Interaction | H2BC8 interactions | REXO4 EP400 ATAD5 POLA1 AHCTF1 WDR70 CHD3 MECP2 PARP1 BRD4 MDC1 NUCKS1 TOP2A TOP2B KIF22 | 1.18e-05 | 576 | 140 | 15 | int:H2BC8 |
| Interaction | RPL18 interactions | REXO4 FN1 RPS6KB2 RPS20 CHD3 HUWE1 MECP2 ZNF771 CD4 BRD4 DDX54 USP15 TOP2A AHNAK2 | 1.36e-05 | 512 | 140 | 14 | int:RPL18 |
| Interaction | POU5F1 interactions | TPR TCF4 EP400 TCOF1 CHD3 HUWE1 DNAJA3 PARP1 AHNAK BRD4 MDC1 FECH USP15 TOP2A TOP2B | 1.39e-05 | 584 | 140 | 15 | int:POU5F1 |
| Interaction | EIF3C interactions | 1.57e-05 | 263 | 140 | 10 | int:EIF3C | |
| Interaction | PAICS interactions | 1.57e-05 | 263 | 140 | 10 | int:PAICS | |
| Interaction | MEX3A interactions | AHCTF1 CHD3 HUWE1 PARP1 GRK2 UBN1 AHNAK MACF1 TACC3 CAMSAP1 TOP2A AHNAK2 | 1.57e-05 | 384 | 140 | 12 | int:MEX3A |
| Interaction | PRPF19 interactions | FN1 TCOF1 MECOM CHD3 CEP192 HUWE1 MECP2 PARP1 SF3B1 BRD4 TAF15 TACC3 TOP2A | 1.58e-05 | 450 | 140 | 13 | int:PRPF19 |
| Interaction | HP1BP3 interactions | REXO4 WDR70 MECOM CHD3 HUWE1 MECP2 PARP1 H1-8 BRD4 NUCKS1 TOP2A | 1.94e-05 | 329 | 140 | 11 | int:HP1BP3 |
| Interaction | SMC5 interactions | TPR REXO4 EP400 ATAD5 AHCTF1 CASP8 RPS20 CHD3 MECP2 PARP1 SF3B1 UBN1 AHNAK BRD4 MDC1 EIF2S2 TAF15 ATP2A1 TOP2A TOP2B | 1.95e-05 | 1000 | 140 | 20 | int:SMC5 |
| Interaction | SMARCA4 interactions | CDK8 EP400 MECOM CHD3 MECP2 PARP1 UBN1 BRD4 MDC1 NUCKS1 TAF15 TOP2A TOP2B | 2.09e-05 | 462 | 140 | 13 | int:SMARCA4 |
| Interaction | XRCC6 interactions | TPR TCF4 REXO4 FN1 EP400 AHCTF1 WDR70 MECOM CHD3 HUWE1 MECP2 PARP1 SF3B1 BRD4 MDC1 EIF2S2 TAF15 TOP2A TOP2B | 2.34e-05 | 928 | 140 | 19 | int:XRCC6 |
| Interaction | NUCKS1 interactions | 2.38e-05 | 220 | 140 | 9 | int:NUCKS1 | |
| Interaction | NUMA1 interactions | AHCTF1 RPS20 CHD3 PARP1 BRD4 MDC1 SSX2IP NUCKS1 MACF1 TAF15 TOP2A TOP2B KIF22 | 2.44e-05 | 469 | 140 | 13 | int:NUMA1 |
| Interaction | RPL29 interactions | 2.85e-05 | 282 | 140 | 10 | int:RPL29 | |
| Interaction | GRIA1 interactions | 3.01e-05 | 86 | 140 | 6 | int:GRIA1 | |
| Interaction | RBM14 interactions | FN1 MECOM GRIA4 RPS20 CHD3 CDK14 MECP2 PARP1 SF3B1 BRD4 MACF1 TAF15 USP15 TOP2B | 3.19e-05 | 553 | 140 | 14 | int:RBM14 |
| Interaction | ADAR interactions | 3.21e-05 | 286 | 140 | 10 | int:ADAR | |
| Interaction | SIRT6 interactions | RGPD8 EP400 TCOF1 CHD3 QRICH1 HUWE1 PARP1 BRD4 MDC1 DDX54 CAMSAP1 USP15 TOP2A TOP2B RGPD5 | 3.22e-05 | 628 | 140 | 15 | int:SIRT6 |
| Interaction | RPL14 interactions | REXO4 FN1 EPB41L4B RPS6KB2 RPS20 CHD3 MECP2 ZNF771 PARP1 AHNAK BRD4 DDX54 MACF1 TOP2A | 3.25e-05 | 554 | 140 | 14 | int:RPL14 |
| Interaction | MCM7 interactions | FN1 TRAIP MECOM CHD3 HUWE1 PARP1 SF3B1 BRD4 SSX2IP NUCKS1 USP15 TOP2B | 3.29e-05 | 414 | 140 | 12 | int:MCM7 |
| Interaction | SRSF2 interactions | 3.61e-05 | 290 | 140 | 10 | int:SRSF2 | |
| Interaction | ANXA2 interactions | FN1 RPS6KB2 SYTL2 CHD3 HUWE1 MECP2 TRIM59 CD4 AHNAK BRD4 TAF15 AHNAK2 | 3.70e-05 | 419 | 140 | 12 | int:ANXA2 |
| Interaction | CTR9 interactions | 3.73e-05 | 233 | 140 | 9 | int:CTR9 | |
| Interaction | ADARB1 interactions | TPR REXO4 TCOF1 AHCTF1 CHD3 POTEKP ZNF771 SF3B1 AHNAK MDC1 DDX54 TOP2A TOP2B | 3.76e-05 | 489 | 140 | 13 | int:ADARB1 |
| Interaction | USP14 interactions | RPS20 DNAJA3 PARP1 AHNAK BRD4 MDC1 EIF2S2 NUCKS1 MACF1 TAF15 USP15 AHNAK2 RGPD5 | 3.76e-05 | 489 | 140 | 13 | int:USP14 |
| Interaction | RCOR1 interactions | TPR NOL4 TCF4 MECOM CHD3 HUWE1 MECP2 ZEB2 AHNAK BRD4 NUCKS1 CAMSAP1 USP15 | 4.17e-05 | 494 | 140 | 13 | int:RCOR1 |
| Interaction | RPS10 interactions | REXO4 FN1 EPB41L4B RPS20 CHD3 HUWE1 MECP2 ZNF771 CD4 SF3B1 BRD4 EIF2S2 DDX54 TOP2A | 4.19e-05 | 567 | 140 | 14 | int:RPS10 |
| Interaction | DLX5 interactions | 4.63e-05 | 29 | 140 | 4 | int:DLX5 | |
| Interaction | KDM1B interactions | 5.13e-05 | 58 | 140 | 5 | int:KDM1B | |
| Interaction | H1-4 interactions | REXO4 TCOF1 EPB41L4B GRIA2 RPS20 CHD3 TACC2 PRX ZNF771 SF3B1 BRD4 DDX54 MACF1 TOP2B KIF22 | 5.29e-05 | 656 | 140 | 15 | int:H1-4 |
| Interaction | MTA2 interactions | MECOM CHD3 MECP2 ZEB2 ZFPM2 PARP1 AHNAK BRD4 NUCKS1 USP15 TOP2A TOP2B | 5.31e-05 | 435 | 140 | 12 | int:MTA2 |
| Interaction | RBBP7 interactions | EP400 TCOF1 RPS6KB2 MECOM CHD3 HUWE1 EZH1 ZEB2 ZFPM2 UBN1 BRD4 NUCKS1 USP15 | 5.44e-05 | 507 | 140 | 13 | int:RBBP7 |
| Interaction | HNRNPAB interactions | FN1 MECOM CHD3 HUWE1 MECP2 PARP1 AHNAK BRD4 MDC1 TAF15 TOP2B | 5.78e-05 | 371 | 140 | 11 | int:HNRNPAB |
| Interaction | EFTUD2 interactions | TPR FN1 TCOF1 POLA1 CARMIL1 RPS20 CHD3 TACC2 HUWE1 MECP2 DARS2 DNAJA3 PARP1 SF3B1 AHNAK BRD4 MDC1 EIF2S2 DDX54 MACF1 TAF15 TOP2A TOP2B AHNAK2 | 5.83e-05 | 1449 | 140 | 24 | int:EFTUD2 |
| Interaction | SIRT7 interactions | TPR REXO4 FN1 TCOF1 POLA1 AHCTF1 HUWE1 ME2 SF3B1 AHNAK BRD4 MDC1 DDX54 MACF1 TAF15 TOP2A | 6.10e-05 | 744 | 140 | 16 | int:SIRT7 |
| Interaction | H1-2 interactions | SLC12A6 REXO4 EP400 TCOF1 CARMIL1 MECOM RPS20 CHD3 PARP1 H1-8 AHNAK BRD4 DDX54 NUCKS1 REV1 | 6.27e-05 | 666 | 140 | 15 | int:H1-2 |
| Interaction | RNF168 interactions | 6.29e-05 | 98 | 140 | 6 | int:RNF168 | |
| Interaction | SMARCC1 interactions | CDK8 CHD3 MECP2 PARP1 UBN1 BRD4 MDC1 NUCKS1 TAF15 USP15 TOP2B | 7.87e-05 | 384 | 140 | 11 | int:SMARCC1 |
| Interaction | UHRF2 interactions | 7.98e-05 | 200 | 140 | 8 | int:UHRF2 | |
| Interaction | CHD4 interactions | TPR NOL4 REXO4 TCOF1 MECOM RPS20 CHD3 MECP2 PARP1 SF3B1 AHNAK BRD4 MDC1 DDX54 TAF15 USP15 TOP2A TOP2B | 8.96e-05 | 938 | 140 | 18 | int:CHD4 |
| Interaction | POLE3 interactions | 9.74e-05 | 106 | 140 | 6 | int:POLE3 | |
| Interaction | SMAD9 interactions | 9.79e-05 | 153 | 140 | 7 | int:SMAD9 | |
| Interaction | RFC5 interactions | 9.81e-05 | 206 | 140 | 8 | int:RFC5 | |
| Interaction | DCPS interactions | TPR AHCTF1 RPS20 PARP1 SF3B1 AHNAK MDC1 DDX54 TAF15 TOP2A TOP2B | 9.88e-05 | 394 | 140 | 11 | int:DCPS |
| Interaction | HNRNPU interactions | TPR RPGRIP1 REXO4 FN1 RPS6KB2 MECOM GRIA2 CHD3 HUWE1 MECP2 SF3B1 PLCH2 BRD4 MDC1 DDX54 TAF15 USP15 FGD6 TOP2A | 1.01e-04 | 1035 | 140 | 19 | int:HNRNPU |
| Interaction | TOP1 interactions | CDK8 TPR EP400 TCOF1 POLA1 TRAIP CHD3 CDK14 MECP2 PARP1 SF3B1 BRD4 TAF15 TOP2A TOP2B | 1.02e-04 | 696 | 140 | 15 | int:TOP1 |
| Interaction | ENO1 interactions | FN1 MAP4K3 POLA1 CHD3 CEP192 QRICH1 HUWE1 CD4 CLK1 MTFR1 AHNAK BRD4 MDC1 TAF15 USP15 | 1.11e-04 | 701 | 140 | 15 | int:ENO1 |
| Interaction | CSNK2A1 interactions | ABCC1 FN1 TCOF1 ATAD5 MECOM RPS20 CHD3 MECP2 ZEB2 SF3B1 BRD4 MDC1 EIF2S2 DDX54 NUCKS1 MACF1 GGA1 TOP2A | 1.14e-04 | 956 | 140 | 18 | int:CSNK2A1 |
| Interaction | CSNK2B interactions | FN1 EP400 TCOF1 RPS6KB2 MECOM MECP2 ZEB2 NUAK2 GRK2 BRD4 EIF2S2 DDX54 TOP2A TOP2B | 1.18e-04 | 625 | 140 | 14 | int:CSNK2B |
| Interaction | ZC3H13 interactions | 1.20e-04 | 158 | 140 | 7 | int:ZC3H13 | |
| Interaction | RPL30 interactions | SLC12A6 REXO4 FN1 MAP4K3 RPS6KB2 RPS20 CHD3 HUWE1 ZNF771 BRD4 DDX54 TOP2A | 1.20e-04 | 474 | 140 | 12 | int:RPL30 |
| Interaction | CAPZB interactions | TPR FN1 DCUN1D5 CARMIL1 RPS20 TACC2 QRICH1 HUWE1 ME2 MECP2 DARS2 PARP1 GPBP1L1 MDC1 EIF2S2 PEAK1 TOP2A TOP2B KIF22 | 1.20e-04 | 1049 | 140 | 19 | int:CAPZB |
| Interaction | KIF20A interactions | RGPD8 AHCTF1 RPS20 POTEKP CDK14 ZEB2 PARP1 SF3B1 AHNAK BRD4 MDC1 NUCKS1 MACF1 TAF15 ATP2A1 UAP1L1 TOP2A TOP2B AHNAK2 | 1.25e-04 | 1052 | 140 | 19 | int:KIF20A |
| Interaction | EIF3B interactions | 1.26e-04 | 337 | 140 | 10 | int:EIF3B | |
| Interaction | TERF2IP interactions | EP400 ATAD5 POLA1 AHCTF1 WDR70 CHD3 PRX PARP1 BRD4 MDC1 MASTL NUCKS1 TOP2A | 1.28e-04 | 552 | 140 | 13 | int:TERF2IP |
| Interaction | DDX23 interactions | REXO4 TCOF1 WDR70 CHD3 MECP2 SF3B1 CLK1 BRD4 DDX54 TAF15 TOP2A TOP2B | 1.35e-04 | 480 | 140 | 12 | int:DDX23 |
| Interaction | EMG1 interactions | 1.39e-04 | 113 | 140 | 6 | int:EMG1 | |
| Interaction | NSD2 interactions | 1.44e-04 | 278 | 140 | 9 | int:NSD2 | |
| Interaction | BRCA1 interactions | CDK8 TPR RPGRIP1 ABCC1 TCOF1 HUWE1 DNAJA3 PARP1 SF3B1 AHNAK BRD4 MDC1 SSX2IP DDX54 TAF15 TACC3 USH2A TOP2A TOP2B KIF22 REV1 | 1.46e-04 | 1249 | 140 | 21 | int:BRCA1 |
| Interaction | CIRBP interactions | 1.51e-04 | 164 | 140 | 7 | int:CIRBP | |
| Interaction | SYNCRIP interactions | FN1 ICE2 MECOM GRIA1 GRIA4 RPS20 CHD3 MECP2 PARP1 SF3B1 BRD4 DDX54 SECISBP2 MACF1 TAF15 | 1.51e-04 | 721 | 140 | 15 | int:SYNCRIP |
| Interaction | RRS1 interactions | 1.52e-04 | 345 | 140 | 10 | int:RRS1 | |
| Interaction | SFPQ interactions | TPR FN1 RPS6KB2 GRIA2 CHD3 HUWE1 MECP2 PARP1 SF3B1 BRD4 MDC1 TAF15 TOP2B | 1.55e-04 | 563 | 140 | 13 | int:SFPQ |
| Interaction | SMARCA5 interactions | TPR REXO4 MECOM CHD3 HUWE1 MECP2 PARP1 SF3B1 BRD4 NUCKS1 USP15 | 1.56e-04 | 415 | 140 | 11 | int:SMARCA5 |
| Interaction | POLR1G interactions | REXO4 EP400 TCOF1 ATAD5 WDR70 HUWE1 MECP2 ZEB2 BRD4 DDX54 TOP2A TOP2B | 1.60e-04 | 489 | 140 | 12 | int:POLR1G |
| Interaction | SRRM1 interactions | 1.63e-04 | 348 | 140 | 10 | int:SRRM1 | |
| Interaction | SMC1A interactions | CDK8 POLA1 MECOM CHD3 HUWE1 MECP2 PARP1 SF3B1 BRD4 MDC1 USP15 | 1.66e-04 | 418 | 140 | 11 | int:SMC1A |
| Interaction | HMGA1 interactions | CDK8 FN1 AHCTF1 MECP2 PARP1 BRD4 MDC1 EIF2S2 CAMSAP1 TOP2A TOP2B | 1.69e-04 | 419 | 140 | 11 | int:HMGA1 |
| Interaction | RPS8 interactions | REXO4 FN1 EPB41L4B RPS6KB2 RPS20 CHD3 HUWE1 MECP2 ZNF771 PARP1 SF3B1 BRD4 DDX54 TOP2A | 1.75e-04 | 649 | 140 | 14 | int:RPS8 |
| Interaction | NOP56 interactions | REXO4 TCOF1 ATAD5 WDR70 MECOM CHD3 MECP2 PARP1 BRD4 EIF2S2 DDX54 TOP2A TOP2B | 1.75e-04 | 570 | 140 | 13 | int:NOP56 |
| Interaction | SMARCE1 interactions | 1.83e-04 | 287 | 140 | 9 | int:SMARCE1 | |
| Interaction | GRIA4 interactions | 1.85e-04 | 41 | 140 | 4 | int:GRIA4 | |
| Interaction | RNF169 interactions | 1.87e-04 | 76 | 140 | 5 | int:RNF169 | |
| Interaction | DDX46 interactions | 1.91e-04 | 227 | 140 | 8 | int:DDX46 | |
| Interaction | RFC4 interactions | 1.91e-04 | 227 | 140 | 8 | int:RFC4 | |
| Interaction | RNF220 interactions | 2.03e-04 | 42 | 140 | 4 | int:RNF220 | |
| Interaction | BRD2 interactions | DCUN1D5 ATAD5 MECOM CHD3 EZH1 MECP2 PARP1 BRD4 MDC1 TOP2A TOP2B | 2.07e-04 | 429 | 140 | 11 | int:BRD2 |
| Interaction | NECAP1 interactions | 2.12e-04 | 78 | 140 | 5 | int:NECAP1 | |
| Interaction | MECP2 interactions | NOL4 REXO4 EP400 TCOF1 GRIA2 RPS20 EZH1 MECP2 ZSCAN29 DNAJA3 PARP1 SF3B1 CLK1 BRD4 EIF2S2 DDX54 NUCKS1 MACF1 TAF15 DLX5 TOP2B | 2.20e-04 | 1287 | 140 | 21 | int:MECP2 |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 8.81e-10 | 4 | 100 | 4 | 1200 | |
| GeneFamily | PAR bZIP family | 9.05e-05 | 3 | 100 | 2 | 1248 | |
| GeneFamily | Topoisomerases | 4.48e-04 | 6 | 100 | 2 | 1050 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.67e-04 | 34 | 100 | 3 | 487 | |
| GeneFamily | ATP binding cassette subfamily C | 2.27e-03 | 13 | 100 | 2 | 807 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.33e-03 | 181 | 100 | 5 | 694 | |
| GeneFamily | BPI fold containing | 3.46e-03 | 16 | 100 | 2 | 456 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.90e-03 | 17 | 100 | 2 | 1291 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | DPYD TCOF1 CARMIL1 MECP2 ZEB2 DARS2 GPC3 PLCH2 BRD4 MACF1 TACC3 | 1.03e-08 | 197 | 141 | 11 | M8980 |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 1.39e-07 | 200 | 141 | 10 | M4584 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 9.63e-07 | 97 | 141 | 7 | M14698 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | FN1 TCOF1 ATAD5 POLA1 TRAIP CEP192 TRIM59 CCNB2 MDC1 NUCKS1 TAF15 TACC3 TOP2A KIF22 | 3.05e-06 | 578 | 141 | 14 | M2368 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 ABCC1 DPYD DOCK9 AHCTF1 CASP8 MECOM ME2 MECP2 ZEB2 NBAS FCHSD2 MTFR1 MACF1 TAF15 USP15 TOP2A | 3.75e-06 | 856 | 141 | 17 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | FN1 TCOF1 ATAD5 POLA1 TRAIP CEP192 TRIM59 CCNB2 MDC1 NUCKS1 TAF15 TACC3 TOP2A KIF22 | 4.43e-06 | 597 | 141 | 14 | MM1309 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 5.07e-06 | 81 | 141 | 6 | M39253 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 5.22e-06 | 176 | 141 | 8 | M2981 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 9.15e-06 | 190 | 141 | 8 | M761 | |
| Coexpression | GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN | 1.24e-05 | 198 | 141 | 8 | M5571 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | ABCC1 NIBAN1 ATAD5 POLA1 TRAIP CCNB2 MDC1 SSX2IP MASTL DLX3 TACC3 FGD6 TOP2A | 1.25e-05 | 567 | 141 | 13 | M45692 |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_DN | 1.33e-05 | 200 | 141 | 8 | M6433 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.81e-05 | 101 | 141 | 6 | M1577 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 3.61e-05 | 168 | 141 | 7 | M45039 | |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 3.97e-05 | 233 | 141 | 8 | M39036 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR NIBAN1 EP400 DOCK9 CASP8 RPS20 CHD3 HUWE1 MECP2 ZEB2 KMT2C PARP1 CD4 SF3B1 GRK2 CLK1 AHNAK SECISBP2 MACF1 USP15 TOP2B | 4.95e-05 | 1492 | 141 | 21 | M40023 |
| Coexpression | ZHONG_PFC_C2_UNKNOWN_NPC | 5.70e-05 | 76 | 141 | 5 | M39087 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | C8orf88 ATAD5 POLA1 TRAIP CHD3 ZNF771 CCNB2 MASTL TACC3 TOP2A KIF22 | 5.79e-05 | 478 | 141 | 11 | M45785 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 6.51e-05 | 250 | 141 | 8 | M11318 | |
| Coexpression | FISCHER_DREAM_TARGETS | TCOF1 ATAD5 POLA1 AHCTF1 TRAIP CEP192 DBP TRIM59 DARS2 CCNB2 MDC1 MASTL NUCKS1 TACC3 TOP2A KIF22 | 6.88e-05 | 969 | 141 | 16 | M149 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 9.85e-05 | 197 | 141 | 7 | M8983 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 9.98e-05 | 341 | 141 | 9 | M2879 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 1.02e-04 | 198 | 141 | 7 | M8041 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN | 1.02e-04 | 198 | 141 | 7 | M6033 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.02e-04 | 198 | 141 | 7 | M5448 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 1.05e-04 | 199 | 141 | 7 | M9414 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP | 1.05e-04 | 199 | 141 | 7 | M8035 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 1.05e-04 | 199 | 141 | 7 | M3583 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 1.05e-04 | 199 | 141 | 7 | M3800 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 1.08e-04 | 200 | 141 | 7 | M8069 | |
| Coexpression | GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP | 1.08e-04 | 200 | 141 | 7 | M5630 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | POLA1 ICE2 AHCTF1 TRAIP RPS20 DARS2 CCNB2 MDC1 MASTL NUCKS1 TACC3 TOP2A KIF22 | 1.32e-04 | 714 | 141 | 13 | M1744 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | TPR FN1 SYTL2 CXCL1 KMT2C SF3B1 AHNAK SSX2IP EIF2S2 CAMSAP1 USP15 TOP2A AHNAK2 | 1.45e-04 | 721 | 141 | 13 | M10237 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.77e-04 | 152 | 141 | 6 | M39243 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 1.81e-04 | 290 | 141 | 8 | M17183 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.84e-04 | 153 | 141 | 6 | M5588 | |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 1.91e-04 | 53 | 141 | 4 | M17537 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.97e-04 | 155 | 141 | 6 | MM1259 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.97e-04 | 155 | 141 | 6 | M39041 | |
| Coexpression | DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS | 2.20e-04 | 101 | 141 | 5 | M40100 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 2.52e-04 | 104 | 141 | 5 | MM1180 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 2.85e-04 | 166 | 141 | 6 | M5354 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP | 2.87e-04 | 107 | 141 | 5 | M7141 | |
| Coexpression | CORRE_MULTIPLE_MYELOMA_DN | 2.90e-04 | 59 | 141 | 4 | M990 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 2.93e-04 | 394 | 141 | 9 | MM3724 | |
| Coexpression | HEVNER_CORTEX_INTERNEURON_PRECURSOR_CELLS | 3.21e-04 | 25 | 141 | 3 | MM400 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.39e-04 | 402 | 141 | 9 | MM454 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 3.66e-04 | 322 | 141 | 8 | M39060 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 3.70e-04 | 113 | 141 | 5 | M39153 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 3.74e-04 | 323 | 141 | 8 | M2156 | |
| Coexpression | LEE_BMP2_TARGETS_DN | UAP1 TCOF1 ATAD5 TRAIP CEP192 TRIM59 DNAJA3 PARP1 MB21D2 MTFR1 EIF2S2 ECRG4 NUCKS1 SECISBP2 | 3.82e-04 | 904 | 141 | 14 | M2325 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 4.02e-04 | 177 | 141 | 6 | M39245 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 4.12e-04 | 249 | 141 | 7 | M1796 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | TCOF1 ICE2 TRAIP SYTL2 IMPACT CDK14 ZNF365 ENTPD4 CCNB2 MDC1 SSX2IP TACC3 MAP2K6 TOP2A KIF22 | 4.19e-04 | 1023 | 141 | 15 | M17122 |
| Coexpression | PETRETTO_HEART_MASS_QTL_CIS_DN | 4.52e-04 | 28 | 141 | 3 | M13336 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 4.53e-04 | 181 | 141 | 6 | M2969 | |
| Coexpression | LEE_BMP2_TARGETS_DN | UAP1 TCOF1 ATAD5 TRAIP CEP192 TRIM59 DNAJA3 PARP1 MB21D2 MTFR1 EIF2S2 ECRG4 NUCKS1 SECISBP2 | 4.65e-04 | 922 | 141 | 14 | MM1068 |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 4.98e-04 | 257 | 141 | 7 | MM1231 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 5.33e-04 | 260 | 141 | 7 | M1471 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 5.59e-04 | 70 | 141 | 4 | M10739 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | NIBAN1 C8orf88 FN1 TRAIP CEP192 TRIM59 GPC3 CCNB2 MASTL UGT8 SCPEP1 PEAK1 TACC3 ROBO3 TOP2A | 5.70e-04 | 1054 | 141 | 15 | M45798 |
| Coexpression | ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN | 5.90e-04 | 71 | 141 | 4 | M3988 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 6.08e-04 | 126 | 141 | 5 | M9362 | |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 6.13e-04 | 31 | 141 | 3 | M3732 | |
| Coexpression | BENPORATH_SOX2_TARGETS | HUWE1 CDK14 ZEB2 DARS2 USP44 NBAS MDC1 NUCKS1 UGT8 TAF15 GGA1 TOP2A | 6.30e-04 | 734 | 141 | 12 | M3835 |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 6.35e-04 | 193 | 141 | 6 | M4961 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | C8orf88 SYTL2 GRIA2 HUWE1 TRIM59 PARP1 MB21D2 HMCN1 CCNB2 AHNAK2 | 6.47e-04 | 534 | 141 | 10 | M12522 |
| Coexpression | TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL | 6.66e-04 | 270 | 141 | 7 | M41699 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 6.70e-04 | 195 | 141 | 6 | M3089 | |
| Coexpression | GSE10325_CD4_TCELL_VS_BCELL_DN | 6.70e-04 | 195 | 141 | 6 | M3077 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP | 6.88e-04 | 196 | 141 | 6 | M5313 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN | 6.88e-04 | 196 | 141 | 6 | M3085 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 6.90e-04 | 74 | 141 | 4 | M4479 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 7.06e-04 | 197 | 141 | 6 | M9569 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP | 7.06e-04 | 197 | 141 | 6 | M9969 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DN | 7.06e-04 | 197 | 141 | 6 | M4946 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN | 7.25e-04 | 198 | 141 | 6 | M3542 | |
| Coexpression | GSE29618_PDC_VS_MDC_UP | 7.25e-04 | 198 | 141 | 6 | M4951 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 7.25e-04 | 198 | 141 | 6 | M3195 | |
| Coexpression | MCCLUNG_COCAINE_REWARD_5D | 7.25e-04 | 75 | 141 | 4 | M1539 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 7.45e-04 | 199 | 141 | 6 | M4607 | |
| Coexpression | GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP | 7.45e-04 | 199 | 141 | 6 | M4970 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN | 7.45e-04 | 199 | 141 | 6 | M4964 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 7.45e-04 | 199 | 141 | 6 | M6932 | |
| Coexpression | GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP | 7.64e-04 | 200 | 141 | 6 | M9437 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 7.64e-04 | 200 | 141 | 6 | M9453 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN | 7.64e-04 | 200 | 141 | 6 | M8037 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 7.64e-04 | 200 | 141 | 6 | M8039 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 7.64e-04 | 200 | 141 | 6 | M8398 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP | 7.64e-04 | 200 | 141 | 6 | M9584 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN | 7.64e-04 | 200 | 141 | 6 | M3712 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP | 7.64e-04 | 200 | 141 | 6 | M7152 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 7.64e-04 | 200 | 141 | 6 | M3811 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 7.64e-04 | 200 | 141 | 6 | M7431 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP | 7.64e-04 | 200 | 141 | 6 | M5049 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP | 7.64e-04 | 200 | 141 | 6 | M5057 | |
| Coexpression | GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP | 7.64e-04 | 200 | 141 | 6 | M6424 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 7.64e-04 | 200 | 141 | 6 | M8954 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN | 7.64e-04 | 200 | 141 | 6 | M5274 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP | 7.64e-04 | 200 | 141 | 6 | M7975 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | ATAD5 POLA1 TRIM59 PARP1 FCHSD2 CCNB2 SETBP1 MASTL TACC3 FGD6 TOP2A KIF22 REV1 | 1.24e-06 | 380 | 138 | 13 | GSM538207_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR TCOF1 ATAD5 KIF26B ICE2 HLF MECOM ABCC9 FCHSD2 PLCH2 EIF2S2 DDX54 BPIFB4 MACF1 DLX5 PEAK1 TACC3 ROBO3 FGD6 JHY | 6.27e-06 | 989 | 138 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | EPB41L4B KIF26B POLA1 GRIA2 RPS20 HUWE1 ZNF365 MECP2 ZEB2 SF3B1 HMCN1 UGT8 GABRA4 | 2.01e-05 | 492 | 138 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | DPYD ATAD5 POLA1 MECOM GRIA1 ABCC9 GRIA4 HUWE1 TRIM59 ZFPM2 MB21D2 HMCN1 ECRG4 ERCC6L2 PLCL1 FGD6 TOP2B | 2.38e-05 | 819 | 138 | 17 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TPR TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 MDC1 EIF2S2 ECRG4 BPIFB4 MACF1 PEAK1 FGD6 UAP1L1 | 2.75e-05 | 744 | 138 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TPR TCF4 NIBAN1 EPB41L4B KIF26B ICE2 CASP8 MECOM ABCC9 CEP192 CDK14 ENTPD4 ZSCAN29 ECRG4 MACF1 PEAK1 FGD6 | 3.00e-05 | 834 | 138 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TCF4 EPB41L4B KIF26B POLA1 GRIA2 RPS20 HUWE1 ZNF365 MECP2 ZEB2 SF3B1 HMCN1 ERCC6L2 UGT8 DLX5 TOP2B GABRA4 | 3.09e-05 | 836 | 138 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | ATAD5 SYTL2 GRIA3 CHD3 TACC2 TRIM59 CCNB2 MASTL TACC3 TOP2A KIF22 | 3.33e-05 | 373 | 138 | 11 | GSM605781_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.72e-05 | 311 | 138 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | NIBAN1 FN1 ATAD5 KIF26B POLA1 SYTL2 ABCC9 GRIA3 GRIA4 ZEB2 ZFPM2 GPC3 HMCN1 PEAK1 TOP2A GABRA4 | 4.35e-05 | 773 | 138 | 16 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CDK8 TPR TCOF1 ATAD5 POLA1 ICE2 AHCTF1 CEP192 ME2 TRIM59 NUAK2 ZSCAN29 BRD4 SETBP1 MDC1 EIF2S2 MASTL MACF1 TAF15 CAMSAP1 TOP2A | 6.21e-05 | 1257 | 138 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | FN1 ATAD5 POLA1 CARMIL1 GRIA3 CCNB2 MASTL SCPEP1 TACC3 TOP2A KIF22 | 6.40e-05 | 401 | 138 | 11 | GSM791114_500 |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | SLC12A6 TCF4 CARMIL1 NUAK2 AHNAK SETBP1 MACF1 SCPEP1 FGD6 AHNAK2 | 7.29e-05 | 337 | 138 | 10 | GSM538228_500 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | FN1 ATAD5 POLA1 HLF MECOM GRIA3 HMCN1 CCNB2 MASTL TACC3 TOP2A | 7.80e-05 | 410 | 138 | 11 | GSM791122_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ATAD5 KIF26B POLA1 SYTL2 IMPACT GRIA3 CHD3 CDK14 TRIM59 ZEB2 ZFPM2 GPC3 HMCN1 MASTL TOP2A GABRA4 | 1.02e-04 | 831 | 138 | 16 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | SLC12A6 TCF4 CARMIL1 TRIM59 PARP1 FCHSD2 AHNAK SETBP1 MACF1 SCPEP1 | 1.04e-04 | 352 | 138 | 10 | GSM538198_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR ATAD5 KIF26B ICE2 HLF ABCC9 FCHSD2 EIF2S2 MACF1 PEAK1 FGD6 | 1.24e-04 | 432 | 138 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 ENTPD4 FECH ECRG4 DLX3 UAP1L1 | 1.25e-04 | 589 | 138 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.29e-04 | 229 | 138 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.65e-04 | 79 | 138 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CDK8 TPR NOL4 TCOF1 ATAD5 POLA1 ICE2 AHCTF1 CEP192 ME2 TRIM59 NUAK2 ZSCAN29 BRD4 SETBP1 MDC1 EIF2S2 MASTL MACF1 TAF15 CAMSAP1 TOP2A | 1.81e-04 | 1459 | 138 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | TCF4 EPB41L4B KIF26B GRIA2 GRIA3 ZNF365 MECP2 HMCN1 DLX5 GABRA4 | 1.82e-04 | 377 | 138 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CDK8 TPR DCUN1D5 ATAD5 ICE2 AHCTF1 SYTL2 RPS20 CEP192 TRIM59 CD4 GPC3 PLCH2 BRD4 EIF2S2 MASTL MACF1 DLX3 TAF15 DLX5 TOP2A TOP2B | 1.98e-04 | 1468 | 138 | 22 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | TPR ABCC1 GRIA1 ABCC9 NUAK2 CD4 PLCH2 MDC1 SSX2IP EIF2S2 BPIFB4 MACF1 DLX3 DLX5 PEAK1 FGD6 JHY | 2.11e-04 | 979 | 138 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 2.29e-04 | 249 | 138 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 2.30e-04 | 388 | 138 | 10 | GSM538352_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | 2.49e-04 | 392 | 138 | 10 | GSM538335_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TCF4 ATAD5 POLA1 CEP192 ME2 FCHSD2 MDC1 EIF2S2 TAF15 USP15 JHY | 2.52e-04 | 469 | 138 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 2.65e-04 | 395 | 138 | 10 | GSM538340_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 2.81e-04 | 398 | 138 | 10 | GSM538338_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 2.81e-04 | 398 | 138 | 10 | GSM399397_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 3.04e-04 | 90 | 138 | 5 | GSM399397_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | TPR TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 ENTPD4 FECH ECRG4 PEAK1 UAP1L1 | 3.10e-04 | 734 | 138 | 14 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | TCF4 NIBAN1 EPB41L4B KIF26B HLF CASP8 MECOM ABCC9 CDK14 ENTPD4 ECRG4 DLX3 PEAK1 | 3.36e-04 | 652 | 138 | 13 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 ENTPD4 FECH DLX3 UAP1L1 | 3.37e-04 | 567 | 138 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 3.70e-04 | 412 | 138 | 10 | GSM605793_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | ATAD5 KIF26B HLF MECOM ABCC9 PLCH2 EIF2S2 BPIFB4 DLX5 PEAK1 ROBO3 | 3.78e-04 | 492 | 138 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.78e-04 | 492 | 138 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | ATAD5 POLA1 SYTL2 GRIA3 TRIM59 CCNB2 MASTL TACC3 TOP2A KIF22 | 3.84e-04 | 414 | 138 | 10 | GSM476660_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | ATAD5 POLA1 GRIA3 TRIM59 PARP1 CCNB2 MASTL TACC3 TOP2A KIF22 | 4.22e-04 | 419 | 138 | 10 | GSM538348_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | POLA1 MECOM GRIA1 GRIA4 HUWE1 ZFPM2 MB21D2 ERCC6L2 PLCL1 FGD6 | 4.38e-04 | 421 | 138 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 4.46e-04 | 422 | 138 | 10 | GSM476658_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | ATAD5 POLA1 GRIA3 TRIM59 PARP1 CCNB2 MASTL TACC3 TOP2A KIF22 | 4.46e-04 | 422 | 138 | 10 | GSM538357_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | ATAD5 POLA1 GRIA3 TRIM59 PARP1 CCNB2 MASTL TACC3 TOP2A KIF22 | 4.46e-04 | 422 | 138 | 10 | GSM538355_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 4.54e-04 | 423 | 138 | 10 | GSM791126_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.62e-04 | 348 | 138 | 9 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 4.72e-04 | 349 | 138 | 9 | GSM476675_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_500 | 4.83e-04 | 56 | 138 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FN1 KIF26B SYTL2 ABCC9 GRIA3 GRIA4 CEP192 ZEB2 ZFPM2 GPC3 HMCN1 MDC1 PEAK1 GABRA4 | 5.47e-04 | 777 | 138 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SLC12A6 DOCK9 EZH1 ME2 KMT2C SF3B1 UBN1 HMCN1 MTFR1 ECRG4 UGT8 SCPEP1 PEAK1 GABRA4 | 5.54e-04 | 778 | 138 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CDK8 TPR NOL4 ATAD5 ME2 ZNF365 TRIM59 NUAK2 ZSCAN29 ZNF771 CD4 BRD4 SETBP1 EIF2S2 MASTL TAF15 CAMSAP1 TOP2A TOP2B REV1 | 5.54e-04 | 1370 | 138 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | TCF4 NIBAN1 FN1 DCUN1D5 KIF26B ICE2 GRIA3 GRIA4 CDK14 ENTPD4 ZFPM2 FCHSD2 GPC3 HMCN1 SETBP1 PTPRQ SCPEP1 PEAK1 | 5.62e-04 | 1166 | 138 | 18 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 GRIA1 ABCC9 CDK14 ENTPD4 CD4 PLCH2 EIF2S2 ECRG4 PLCL1 PEAK1 | 6.00e-04 | 878 | 138 | 15 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 6.02e-04 | 361 | 138 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 6.02e-04 | 361 | 138 | 9 | GSM538219_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TPR NIBAN1 KIF26B ICE2 MECOM CHD3 CEP192 PLCH2 ECRG4 MACF1 DLX3 DLX5 PLCL1 PEAK1 ROBO3 FGD6 | 6.26e-04 | 978 | 138 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TCOF1 ATAD5 POLA1 ICE2 MECOM NUAK2 USP44 PLCH2 SETBP1 EIF2S2 TAF15 ROBO3 USP15 FGD6 TOP2B JHY | 7.06e-04 | 989 | 138 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.52e-04 | 298 | 138 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 7.59e-04 | 373 | 138 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.15e-04 | 168 | 138 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | NOL4 TCF4 NIBAN1 FN1 KIF26B GRIA3 GRIA4 CDK14 ZNF365 ENTPD4 CD4 MB21D2 GRK2 GPC3 HMCN1 SETBP1 SCPEP1 PEAK1 | 8.46e-04 | 1208 | 138 | 18 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 8.56e-04 | 304 | 138 | 8 | GSM538354_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.62e-04 | 234 | 138 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | POLA1 ICE2 CEP192 HUWE1 DARS2 ZSCAN29 KMT2C CCNB2 MDC1 ERCC6L2 MASTL UGT8 FGD6 REV1 | 9.22e-04 | 820 | 138 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 9.31e-04 | 308 | 138 | 8 | GSM605775_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 ENTPD4 FECH ECRG4 PEAK1 UAP1L1 | 9.76e-04 | 731 | 138 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | KIF26B POLA1 SYTL2 IMPACT GRIA3 CDK14 ME2 ZEB2 ZFPM2 GPC3 HMCN1 MASTL TOP2A GABRA4 | 1.00e-03 | 827 | 138 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 ENTPD4 ECRG4 PEAK1 UAP1L1 | 1.00e-03 | 642 | 138 | 12 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CDK8 TPR DCUN1D5 ATAD5 ICE2 AHCTF1 RPS20 CEP192 TRIM59 CD4 GPC3 BRD4 EIF2S2 MASTL MACF1 TAF15 TOP2A TOP2B | 1.15e-03 | 1241 | 138 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | TCF4 NIBAN1 EPB41L4B KIF26B CASP8 MECOM ABCC9 CDK14 FECH ECRG4 PEAK1 UAP1L1 | 1.19e-03 | 655 | 138 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | NOL4 NIBAN1 FN1 EPB41L4B KIF26B ICE2 GRIA3 GRIA4 CDK14 ZFPM2 CD4 MB21D2 GPC3 HMCN1 SETBP1 PTPRQ PEAK1 | 1.27e-03 | 1148 | 138 | 17 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.28e-03 | 402 | 138 | 9 | GSM605898_500 | |
| CoexpressionAtlas | B cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3 | 1.31e-03 | 325 | 138 | 8 | GSM538222_500 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-09 | 169 | 142 | 9 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-09 | 180 | 142 | 9 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-09 | 180 | 142 | 9 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.25e-08 | 193 | 142 | 9 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-08 | 193 | 142 | 9 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-08 | 194 | 142 | 9 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-08 | 196 | 142 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.49e-08 | 197 | 142 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.49e-08 | 197 | 142 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-08 | 198 | 142 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.70e-08 | 200 | 142 | 9 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.70e-08 | 200 | 142 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.70e-08 | 200 | 142 | 9 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.39e-08 | 166 | 142 | 8 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.04e-08 | 171 | 142 | 8 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.04e-08 | 171 | 142 | 8 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.79e-08 | 173 | 142 | 8 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-07 | 176 | 142 | 8 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-07 | 176 | 142 | 8 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-07 | 179 | 142 | 8 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-07 | 179 | 142 | 8 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 180 | 142 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-07 | 182 | 142 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-07 | 182 | 142 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-07 | 182 | 142 | 8 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-07 | 183 | 142 | 8 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-07 | 184 | 142 | 8 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-07 | 185 | 142 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.60e-07 | 187 | 142 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-07 | 188 | 142 | 8 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.88e-07 | 191 | 142 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.96e-07 | 192 | 142 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-07 | 193 | 142 | 8 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.12e-07 | 194 | 142 | 8 | f0c113edb706d53792892115b67277a285219942 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-07 | 194 | 142 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-07 | 196 | 142 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 197 | 142 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.57e-07 | 199 | 142 | 8 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-07 | 199 | 142 | 8 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | TCGA-Breast-Primary_Tumor|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.57e-07 | 199 | 142 | 8 | 82f308d4b047db049fc5ce9ff60e26cf0e1255a5 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.57e-07 | 199 | 142 | 8 | 875ee4a85dfdfcaaf61c09ed65cebafc6acbbaf0 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.67e-07 | 200 | 142 | 8 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.67e-07 | 200 | 142 | 8 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.49e-07 | 163 | 142 | 7 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 165 | 142 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-06 | 166 | 142 | 7 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-06 | 166 | 142 | 7 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 167 | 142 | 7 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-06 | 170 | 142 | 7 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-06 | 171 | 142 | 7 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-06 | 172 | 142 | 7 | 282017db72d0537ac82aecc69393ccde9590be60 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-06 | 174 | 142 | 7 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-06 | 174 | 142 | 7 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-06 | 174 | 142 | 7 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-06 | 174 | 142 | 7 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-06 | 175 | 142 | 7 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-06 | 175 | 142 | 7 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 177 | 142 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 177 | 142 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-06 | 180 | 142 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 180 | 142 | 7 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 181 | 142 | 7 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 181 | 142 | 7 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 182 | 142 | 7 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-06 | 182 | 142 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 182 | 142 | 7 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 184 | 142 | 7 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 186 | 142 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.29e-06 | 186 | 142 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 186 | 142 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 187 | 142 | 7 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 188 | 142 | 7 | a6ad6de6aeaf213952124252c1452b73942a0c3d | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 2.46e-06 | 188 | 142 | 7 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.46e-06 | 188 | 142 | 7 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.55e-06 | 189 | 142 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-06 | 189 | 142 | 7 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 190 | 142 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 190 | 142 | 7 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.64e-06 | 190 | 142 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 190 | 142 | 7 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.64e-06 | 190 | 142 | 7 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.64e-06 | 190 | 142 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-06 | 191 | 142 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 191 | 142 | 7 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 191 | 142 | 7 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-06 | 191 | 142 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.73e-06 | 191 | 142 | 7 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-06 | 191 | 142 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-06 | 192 | 142 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.82e-06 | 192 | 142 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-06 | 192 | 142 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-06 | 192 | 142 | 7 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 2.82e-06 | 192 | 142 | 7 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-06 | 193 | 142 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.92e-06 | 193 | 142 | 7 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-06 | 193 | 142 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| Drug | 3-pyridazinol 1-oxide | 1.45e-09 | 4 | 142 | 4 | CID000574311 | |
| Drug | AC1L1YEG | 7.22e-09 | 5 | 142 | 4 | CID000063114 | |
| Drug | Chicago acid | 7.22e-09 | 5 | 142 | 4 | CID000065740 | |
| Drug | CHEBI:570577 | 7.22e-09 | 5 | 142 | 4 | CID011334126 | |
| Drug | 1-BCP | 7.22e-09 | 5 | 142 | 4 | CID000001370 | |
| Drug | irampanel | 7.22e-09 | 5 | 142 | 4 | CID003038472 | |
| Drug | LY395153 | 7.22e-09 | 5 | 142 | 4 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 7.22e-09 | 5 | 142 | 4 | CID000107978 | |
| Drug | 5-h PCA | 7.22e-09 | 5 | 142 | 4 | CID000129091 | |
| Drug | YM928 | 2.15e-08 | 6 | 142 | 4 | CID006918393 | |
| Drug | 2cmo | 2.15e-08 | 6 | 142 | 4 | CID006914597 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 5.00e-08 | 7 | 142 | 4 | CID000127988 | |
| Drug | thio-ATPA | 5.00e-08 | 7 | 142 | 4 | CID005289517 | |
| Drug | homoibotenic acid | 9.96e-08 | 8 | 142 | 4 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 9.96e-08 | 8 | 142 | 4 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 9.96e-08 | 8 | 142 | 4 | CID003614351 | |
| Drug | 2,3-PDCA | 9.96e-08 | 8 | 142 | 4 | CID000127037 | |
| Drug | 1m5b | 1.78e-07 | 9 | 142 | 4 | CID000447081 | |
| Drug | Ly294486 | 1.78e-07 | 9 | 142 | 4 | CID005311255 | |
| Drug | isothiazol-3-one | 1.78e-07 | 9 | 142 | 4 | CID000096917 | |
| Drug | L000369 | 1.99e-07 | 41 | 142 | 6 | CID003931705 | |
| Drug | Benzoates | 2.96e-07 | 10 | 142 | 4 | ctd:D001565 | |
| Drug | Ns102 | 4.22e-07 | 25 | 142 | 5 | CID005311098 | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.62e-07 | 197 | 142 | 10 | 4814_DN | |
| Drug | J-ST | 4.63e-07 | 11 | 142 | 4 | CID005288655 | |
| Drug | YM872 | 4.63e-07 | 11 | 142 | 4 | CID000148200 | |
| Drug | 0-ol | 4.63e-07 | 11 | 142 | 4 | CID000069892 | |
| Drug | sym 2206 | 4.63e-07 | 11 | 142 | 4 | CID005039877 | |
| Drug | Atpa | 6.91e-07 | 12 | 142 | 4 | CID000002252 | |
| Drug | 1NaPP1 | 6.91e-07 | 12 | 142 | 4 | CID000004877 | |
| Drug | C-X6 | 6.91e-07 | 12 | 142 | 4 | CID005288002 | |
| Drug | sunifiram | 9.46e-07 | 4 | 142 | 3 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 9.46e-07 | 4 | 142 | 3 | CID011105661 | |
| Drug | 3-isoxazolol | 9.46e-07 | 4 | 142 | 3 | CID009964065 | |
| Drug | Naspm | 9.93e-07 | 13 | 142 | 4 | CID000129695 | |
| Drug | quinoxaline-2,3-dione | 1.38e-06 | 14 | 142 | 4 | CID011469229 | |
| Drug | aurintricarboxylic acid | 1.65e-06 | 91 | 142 | 7 | CID000002259 | |
| Drug | thiokynurenic acid | 1.88e-06 | 15 | 142 | 4 | CID003035667 | |
| Drug | ascididemin | 2.35e-06 | 5 | 142 | 3 | CID000189219 | |
| Drug | LY233536 | 2.49e-06 | 16 | 142 | 4 | CID000126239 | |
| Drug | decahydroisoquinoline | 2.49e-06 | 16 | 142 | 4 | CID000097812 | |
| Drug | R,S)-AMPA | 2.84e-06 | 36 | 142 | 5 | CID000001221 | |
| Drug | PPNDS | 3.24e-06 | 17 | 142 | 4 | CID005961627 | |
| Drug | 7-Cl-Thio-Kyna | 3.24e-06 | 17 | 142 | 4 | CID003035668 | |
| Drug | MNQX | 4.15e-06 | 18 | 142 | 4 | CID000130818 | |
| Drug | LY382884 | 5.23e-06 | 19 | 142 | 4 | CID000656723 | |
| Drug | IDRA 21 | 6.50e-06 | 20 | 142 | 4 | CID000003688 | |
| Drug | Joro spider toxin | 6.99e-06 | 43 | 142 | 5 | CID000119582 | |
| Drug | AC1L1DME | 7.48e-06 | 75 | 142 | 6 | CID000002414 | |
| Drug | saclofen | 7.85e-06 | 44 | 142 | 5 | CID000122150 | |
| Drug | AC1L1B62 | 7.99e-06 | 21 | 142 | 4 | CID000001299 | |
| Drug | 2H-1,2,4-benzothiadiazine | 8.16e-06 | 7 | 142 | 3 | CID000473368 | |
| Drug | AC1L1IS7 | 8.79e-06 | 45 | 142 | 5 | CID000004711 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | RPGRIP1 NOL4 FN1 EP400 ATAD5 KIF26B POLA1 ICE2 TRAIP BPIFB6 ENTPD4 TRIM59 PRX USP44 PARP1 CCNB2 PLCH2 SETBP1 INSM2 TACC3 UAP1L1 TOP2A TTLL13 WDR72 | 9.47e-06 | 1441 | 142 | 24 | ctd:C009828 |
| Drug | NS 102 | 9.72e-06 | 22 | 142 | 4 | CID005282252 | |
| Drug | CX516 | 9.72e-06 | 22 | 142 | 4 | CID000148184 | |
| Drug | Fe-mo-s Cluster | 9.72e-06 | 22 | 142 | 4 | CID000445682 | |
| Drug | Epirubicin | 1.09e-05 | 47 | 142 | 5 | ctd:D015251 | |
| Drug | Iem 1460 | 1.30e-05 | 8 | 142 | 3 | CID003248290 | |
| Drug | m-cresol | 1.35e-05 | 83 | 142 | 6 | CID000000342 | |
| Drug | pD 8 | 1.40e-05 | 24 | 142 | 4 | CID000656948 | |
| Drug | CGP 39653 | 1.40e-05 | 24 | 142 | 4 | CID006437837 | |
| Drug | thiocyanate | 1.54e-05 | 85 | 142 | 6 | CID000000781 | |
| Drug | Benzamide | 1.65e-05 | 86 | 142 | 6 | CID000002331 | |
| Drug | Quinoxaline | 1.81e-05 | 52 | 142 | 5 | CID000007045 | |
| Drug | xenon | 1.88e-05 | 88 | 142 | 6 | CID000023991 | |
| Drug | LY339434 | 1.94e-05 | 9 | 142 | 3 | CID006324635 | |
| Drug | 2,4,4'-trichlorobiphenyl | RPGRIP1 NOL4 FN1 EP400 ATAD5 KIF26B POLA1 ICE2 TRAIP BPIFB6 ENTPD4 TRIM59 PRX USP44 CCNB2 PLCH2 SETBP1 INSM2 TACC3 UAP1L1 TOP2A TTLL13 WDR72 | 2.10e-05 | 1411 | 142 | 23 | ctd:C081766 |
| Drug | isoxazole | 2.60e-05 | 56 | 142 | 5 | CID000009254 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.73e-05 | 191 | 142 | 8 | 4168_DN | |
| Drug | AC1NUW3V | 3.05e-05 | 29 | 142 | 4 | CID005462126 | |
| Drug | rufinamide | 3.05e-05 | 29 | 142 | 4 | CID000129228 | |
| Drug | ellipticine | 3.05e-05 | 29 | 142 | 4 | ctd:C034192 | |
| Drug | GYKI 52466 | 3.09e-05 | 58 | 142 | 5 | CID000003538 | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 6158_UP | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 7202_DN | |
| Drug | LY293558 | 3.50e-05 | 30 | 142 | 4 | CID000127894 | |
| Drug | AC1L32TU | 3.50e-05 | 30 | 142 | 4 | CID000107831 | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 3.52e-05 | 198 | 142 | 8 | 5075_UP | |
| Drug | 3,5-dihydroxyphenylglycine | 3.64e-05 | 60 | 142 | 5 | CID000108001 | |
| Drug | Phenobarbital | 3.78e-05 | 11 | 142 | 3 | DB01174 | |
| Drug | 3',4'-dihydroxyflavone | 3.78e-05 | 11 | 142 | 3 | ctd:C028288 | |
| Drug | Prodigiosin | 3.78e-05 | 11 | 142 | 3 | ctd:D011353 | |
| Drug | tetra-O-methyl-NDGA | 3.78e-05 | 11 | 142 | 3 | CID000097616 | |
| Drug | Dexrazoxane | 3.86e-05 | 2 | 142 | 2 | DB00380 | |
| Drug | 2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid | 3.86e-05 | 2 | 142 | 2 | ctd:C474829 | |
| Drug | F14512 | 3.86e-05 | 2 | 142 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 3.86e-05 | 2 | 142 | 2 | DB00694 | |
| Drug | 4-bromohomoibotenic acid | 3.86e-05 | 2 | 142 | 2 | ctd:C023366 | |
| Drug | 5-fluorowillardiine | 3.86e-05 | 2 | 142 | 2 | ctd:C095178 | |
| Drug | 4-methylglutamic acid | 4.00e-05 | 31 | 142 | 4 | CID000005365 | |
| Drug | zoledronic acid | NIBAN1 EP400 TRAIP HLF SYTL2 CASP8 CXCL1 ZNF365 ADAM28 PARP1 MB21D2 GPC3 HMCN1 CCNB2 SETBP1 SSX2IP FECH UGT8 TACC3 MUSK TOP2A AHNAK2 WDR72 | 4.06e-05 | 1472 | 142 | 23 | ctd:C088658 |
| Drug | alpha-methyl-4-carboxyphenylglycine | 4.55e-05 | 32 | 142 | 4 | CID000001222 | |
| Drug | KW-6002 | 4.55e-05 | 32 | 142 | 4 | CID005311037 | |
| Drug | willardine | 4.55e-05 | 32 | 142 | 4 | CID000005123 | |
| Drug | deoxynivalenol | EP400 TCOF1 CASP8 CXCL1 ZEB2 PARP1 AHNAK EIF2S2 NUCKS1 USP15 MAP2K6 TOP2B | 5.02e-05 | 481 | 142 | 12 | ctd:C007262 |
| Drug | 6,7-dinitroquinoxaline | 5.16e-05 | 33 | 142 | 4 | CID002724608 | |
| Drug | NSC406942 | POLA1 GRIA1 GRIA2 GRIA3 GRIA4 ME2 ENTPD4 CD4 GRK2 FECH SECISBP2 SCPEP1 ATP2A1 | 5.54e-05 | 565 | 142 | 13 | CID000001115 |
| Drug | D-CPPene | 5.82e-05 | 34 | 142 | 4 | CID006435801 | |
| Drug | kainite | 6.53e-05 | 35 | 142 | 4 | CID000164810 | |
| Disease | central nervous system disease (implicated_via_orthology) | 8.21e-07 | 16 | 139 | 4 | DOID:331 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | ABCC1 DPYD FN1 RPS6KB2 CASP8 MECOM ZNF365 ZEB2 PARP1 SETBP1 EIF2S2 TOP2A | 7.66e-06 | 525 | 139 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | ABCC1 DPYD FN1 RPS6KB2 CASP8 MECOM ZNF365 ZEB2 PARP1 SETBP1 EIF2S2 TOP2A | 7.66e-06 | 525 | 139 | 12 | C1257931 |
| Disease | Mammary Neoplasms | ABCC1 DPYD FN1 RPS6KB2 CASP8 MECOM ZNF365 ZEB2 PARP1 SETBP1 EIF2S2 TOP2A | 7.95e-06 | 527 | 139 | 12 | C1458155 |
| Disease | Intellectual Disability | CDK8 GRIA1 GRIA2 CHD3 QRICH1 MECP2 KMT2C PARP1 BRD4 SETBP1 MACF1 | 9.38e-06 | 447 | 139 | 11 | C3714756 |
| Disease | Breast Carcinoma | ABCC1 DPYD FN1 RPS6KB2 CASP8 MECOM ZNF365 ZEB2 PARP1 SETBP1 EIF2S2 TOP2A | 9.78e-06 | 538 | 139 | 12 | C0678222 |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.18e-05 | 12 | 139 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | B cell deficiency (implicated_via_orthology) | 2.20e-05 | 2 | 139 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ABCC1 DPYD FN1 RPS6KB2 CASP8 MECOM TACC2 ZNF365 ZEB2 PARP1 SETBP1 EIF2S2 MACF1 GGA1 TOP2A GABRA4 | 4.85e-05 | 1074 | 139 | 16 | C0006142 |
| Disease | waist-hip ratio | DPYD FN1 DCUN1D5 EPB41L4B TRAIP SYTL2 DGKQ MECOM CEP192 EZH1 DNAJA3 UBN1 AHNAK SETBP1 DNAH17 ATP2A1 MAP2K6 | 6.75e-05 | 1226 | 139 | 17 | EFO_0004343 |
| Disease | Myeloid Leukemia | 7.93e-05 | 18 | 139 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 7.93e-05 | 18 | 139 | 3 | C0023466 | |
| Disease | forced expiratory volume | ATAD5 CARMIL1 DOCK9 TRAIP MECOM ZNF365 GPC3 AHNAK ERCC6L2 NUCKS1 PLCL1 FGD6 TOP2B | 9.57e-05 | 789 | 139 | 13 | EFO_0004314 |
| Disease | unipolar depression, bipolar disorder | 9.98e-05 | 156 | 139 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Peripheral Nervous System Diseases | 1.24e-04 | 54 | 139 | 4 | C4721453 | |
| Disease | Liver carcinoma | 1.52e-04 | 507 | 139 | 10 | C2239176 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.87e-04 | 60 | 139 | 4 | C4722327 | |
| Disease | cortical thickness | TCF4 DOCK9 MECOM ABCC9 TACC2 ME2 SF3B1 UBN1 EIF2S2 NUCKS1 MACF1 DLX5 TACC3 USP15 MUSK | 2.52e-04 | 1113 | 139 | 15 | EFO_0004840 |
| Disease | Prostate cancer, familial | 3.22e-04 | 69 | 139 | 4 | C2931456 | |
| Disease | platelet-derived growth factor receptor beta measurement | 3.26e-04 | 6 | 139 | 2 | EFO_0008265 | |
| Disease | Psychosexual Disorders | 3.26e-04 | 6 | 139 | 2 | C0033953 | |
| Disease | Hypoactive Sexual Desire Disorder | 3.26e-04 | 6 | 139 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 3.26e-04 | 6 | 139 | 2 | C0036902 | |
| Disease | Frigidity | 3.26e-04 | 6 | 139 | 2 | C0016722 | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 3.26e-04 | 6 | 139 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | Orgasmic Disorder | 3.26e-04 | 6 | 139 | 2 | C0029261 | |
| Disease | Bipolar Disorder | 4.49e-04 | 477 | 139 | 9 | C0005586 | |
| Disease | neuroimaging measurement | TCF4 KIF26B CARMIL1 DOCK9 TACC2 C9orf153 DNAJA3 NUCKS1 MACF1 PLCL1 TACC3 ROBO3 FGD6 MUSK | 5.41e-04 | 1069 | 139 | 14 | EFO_0004346 |
| Disease | C-reactive protein measurement | RPGRIP1 TCF4 DPYD CARMIL1 TRAIP GRIA1 CEP192 ZFPM2 USP44 AHNAK DNAH17 MACF1 MUSK TOP2B WDR72 | 5.82e-04 | 1206 | 139 | 15 | EFO_0004458 |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 6.06e-04 | 8 | 139 | 2 | C0796250 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.34e-04 | 145 | 139 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | leukodystrophy (implicated_via_orthology) | 7.76e-04 | 9 | 139 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | isovalerate measurement | 7.76e-04 | 9 | 139 | 2 | EFO_0021051 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 7.76e-04 | 9 | 139 | 2 | OBA_2045095 | |
| Disease | Craniofacial Abnormalities | 8.82e-04 | 156 | 139 | 5 | C0376634 | |
| Disease | cerebral palsy (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 9.95e-04 | 93 | 139 | 4 | C1535926 | |
| Disease | Disease Exacerbation | 1.13e-03 | 165 | 139 | 5 | C0235874 | |
| Disease | Semantic-Pragmatic Disorder | 1.18e-03 | 11 | 139 | 2 | C0454655 | |
| Disease | Paranoia | 1.18e-03 | 11 | 139 | 2 | C1456784 | |
| Disease | Auditory Processing Disorder, Central | 1.18e-03 | 11 | 139 | 2 | C0751257 | |
| Disease | Language Delay | 1.18e-03 | 11 | 139 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.18e-03 | 11 | 139 | 2 | C0023014 | |
| Disease | Speech Delay | 1.18e-03 | 11 | 139 | 2 | C0241210 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.30e-03 | 100 | 139 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.31e-03 | 346 | 139 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 1.41e-03 | 12 | 139 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 1.41e-03 | 12 | 139 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | sodium measurement | 1.45e-03 | 103 | 139 | 4 | EFO_0009282 | |
| Disease | Malignant mesothelioma | 1.79e-03 | 109 | 139 | 4 | C0345967 | |
| Disease | Alopecia, Male Pattern | 2.22e-03 | 15 | 139 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 2.22e-03 | 15 | 139 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 2.22e-03 | 15 | 139 | 2 | C0263477 | |
| Disease | Cocaine-Related Disorders | 2.32e-03 | 117 | 139 | 4 | C0236736 | |
| Disease | C-X-C motif chemokine 6 measurement | 2.53e-03 | 16 | 139 | 2 | EFO_0008059 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 2.86e-03 | 17 | 139 | 2 | EFO_0021049 | |
| Disease | Amelogenesis imperfecta | 2.86e-03 | 17 | 139 | 2 | cv:C0002452 | |
| Disease | cancer | 2.95e-03 | 400 | 139 | 7 | MONDO_0004992 | |
| Disease | acylcarnitine measurement | 3.12e-03 | 127 | 139 | 4 | EFO_0005059 | |
| Disease | Cocaine Abuse | 3.12e-03 | 127 | 139 | 4 | C0009171 | |
| Disease | platelet component distribution width | 3.14e-03 | 755 | 139 | 10 | EFO_0007984 | |
| Disease | mood instability measurement | 3.20e-03 | 128 | 139 | 4 | EFO_0008475 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.21e-03 | 18 | 139 | 2 | EFO_1000649, HP_0000131 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 3.57e-03 | 19 | 139 | 2 | OBA_2045179 | |
| Disease | Pseudopelade | 3.57e-03 | 19 | 139 | 2 | C0086873 | |
| Disease | Alopecia | 3.57e-03 | 19 | 139 | 2 | C0002170 | |
| Disease | response to methotrexate, neurotoxicity | 3.57e-03 | 19 | 139 | 2 | EFO_0011057, GO_0031427 | |
| Disease | Seizures | 3.80e-03 | 218 | 139 | 5 | C0036572 | |
| Disease | Microcephaly | 3.93e-03 | 67 | 139 | 3 | C0025958 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.93e-03 | 67 | 139 | 3 | C3463824 | |
| Disease | coagulation factor V measurement | 3.96e-03 | 20 | 139 | 2 | EFO_0008087 | |
| Disease | citrulline measurement | 3.96e-03 | 20 | 139 | 2 | EFO_0009777 | |
| Disease | coronary artery disease | CDK8 DPYD FN1 CARMIL1 DOCK9 MECOM QRICH1 ZEB2 ZFPM2 PARP1 PLCL1 FGD6 WDR72 | 4.29e-03 | 1194 | 139 | 13 | EFO_0001645 |
| Disease | Cocaine Dependence | 4.30e-03 | 139 | 139 | 4 | C0600427 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 4.36e-03 | 21 | 139 | 2 | OBA_2045076 | |
| Disease | ascending aortic diameter | 4.41e-03 | 140 | 139 | 4 | EFO_0021787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KNVPGKMKVAPLFLV | 786 | Q96QE3 | |
| NTGMKKVPKKLEEIP | 341 | Q96L91 | |
| AIPIKQGMLLKRSGK | 326 | Q5VTM2 | |
| LMLQKREAPVPTKTK | 36 | Q9H1Z8 | |
| GTRPHKQKRKPQMVK | 706 | Q9UKQ2 | |
| TPVAPKKDLKIKNMG | 1186 | O60885 | |
| PPSVMLQKDKALVKV | 486 | P59827 | |
| KEMISLLSPQKKKPR | 286 | Q9Y2D8 | |
| APSIMKIKIIAPPKR | 321 | Q9BYX7 | |
| LNPASPIVKKIIEKM | 86 | P09341 | |
| KQQTPEKLPIPMIAK | 516 | Q96GX5 | |
| AGPKVHMLRKAKQKP | 906 | P52824 | |
| MPDVGLNLKAPKLKT | 1581 | Q09666 | |
| KGPKMKGDVVVSLPK | 3681 | Q09666 | |
| IKLPKMKLPQFGIST | 5401 | Q09666 | |
| KGKPVPRIAELMDKK | 861 | Q12882 | |
| KPIDLKAIGKLPIAM | 241 | O60706 | |
| EPQPAEKIGKMKKLR | 6 | O94921 | |
| MPAVLKPAKEKQVIT | 596 | Q5T5Y3 | |
| MVNGKPKKVRKPRTI | 121 | O60479 | |
| EVRMVNGKPKKVRKP | 126 | P56178 | |
| MPVKKKRKSPGVAAA | 1 | Q9BTE7 | |
| PLTGPVKEKIMAVIK | 536 | O14983 | |
| VPKMKNKPRSPVVEL | 661 | P25098 | |
| GPLPKHMIQKTRKRK | 396 | P49759 | |
| QIGIIKTNKKTGKPM | 256 | Q92804 | |
| VLQPVKKRKVDMPIT | 241 | Q2TAL8 | |
| VVKKLPVPLESVKQM | 731 | Q99666 | |
| VVKKLPVPLESVKQM | 731 | O14715 | |
| TKSKLPKPVQDLIKM | 661 | P09874 | |
| LPKVNAKIVAMPKNL | 396 | Q9UPP5 | |
| KMEPQSPGEVKKLQK | 721 | Q03112 | |
| METKKLIGKPLQPAR | 1 | P0DMB2 | |
| EKKMPKPRLKATVTP | 166 | Q9H1E3 | |
| KMALTKNPKKRPTAE | 251 | Q8IVH8 | |
| HKKKIQPRKMAPATA | 131 | Q8IZA3 | |
| PKIGMGKPAITKRKF | 821 | Q8NEZ4 | |
| TPVVIPMKKRKIFHG | 341 | Q14676 | |
| LSEIQKKPQRGMPKV | 196 | Q8IYB1 | |
| MSKRKLIPKLSIQSP | 1 | Q6NUN7 | |
| PPSAKQPSKMLVIKK | 186 | Q9HC44 | |
| KMKGPEPVVSQIIDK | 451 | P51654 | |
| MEVQTKKVRKVPPGL | 166 | P15884 | |
| KVKDTPGLGKVKVML | 441 | Q2KJY2 | |
| KTKAQVPMVLTAGPK | 141 | Q8WW38 | |
| IMKKGYKVPTPIQRK | 111 | Q8TDD1 | |
| ISIMIKKPQKSKPGV | 521 | P42262 | |
| SIMIKKPQKSKPGVF | 531 | P42263 | |
| GISIMIKKPQKSKPG | 521 | P48058 | |
| TGAKPLKKAVVMPLQ | 521 | Q14807 | |
| PKKMIIRANTEPISK | 1156 | Q9H792 | |
| RPKLKKMKSQTGQVG | 236 | O14511 | |
| TGMKKVPKKLEEIPP | 331 | Q6ZTU2 | |
| QSAVPKVMKVKLQPP | 561 | Q9UJY5 | |
| KVMKVKLQPPSGTEL | 566 | Q9UJY5 | |
| IQMEKAKRKTSKPPQ | 346 | P48169 | |
| KPQPMIKKARKVFIP | 206 | Q16534 | |
| AGEKRKFVMKPPQVV | 196 | P20042 | |
| KFVMKPPQVVRVGTK | 201 | P20042 | |
| LPEEQPQTTKLKGKM | 3666 | Q7Z6Z7 | |
| APVVCPKQVKMVLSK | 191 | Q9P2X3 | |
| PAAAGIKKPKAMRKL | 211 | Q96T92 | |
| ISKLVPKIPEKDGQM | 1826 | A2RRP1 | |
| PPVMILKKKRSIGAS | 176 | P09884 | |
| RGLNKPSKIPTMSKK | 7361 | Q9UPN3 | |
| PMIEIRNPLGKLIKK | 256 | Q96RW7 | |
| MKKVPIKPEQPEKLR | 1 | Q9UMZ3 | |
| AGKTLVKNNPKKPEM | 221 | Q15390 | |
| EKVKTTIGMVLLPKP | 76 | Q659A1 | |
| KPEKMAKLPVILGNL | 571 | Q9BZ29 | |
| ASVKPVQMEKLAPKG | 76 | O95067 | |
| VMSGKIKGKTLLPIP | 151 | Q9UFH2 | |
| RVTPKEKTGPMKEIN | 1846 | P02751 | |
| SQFMRPLIAKKNPKI | 166 | Q12873 | |
| PPVLVKKEKEMVGAL | 1966 | Q12873 | |
| GIAKAAKIIIVPPIM | 16 | Q16880 | |
| LQPVISVNKMNKPGK | 76 | Q5TBE3 | |
| VTQDPKLQMGKKLPL | 266 | P01730 | |
| KIFQPGMVVPSKTKI | 156 | O15033 | |
| PGMKPIKGITNLKVK | 56 | Q8NFQ5 | |
| KQMPQPTFTLRKKLV | 461 | Q14790 | |
| IKEKGKPLMLNPRTN | 21 | P23368 | |
| VKPMTKPPSTKVEIR | 2261 | Q8TEP8 | |
| KPQPIMKKARKIQVP | 236 | Q10586 | |
| KIFPGLSPVRIMKKV | 116 | Q5VZK9 | |
| DVATPKMPGQSVRKK | 1761 | Q8WYP5 | |
| PKKVLSGPMEKAKQR | 1471 | Q5T890 | |
| MQPPPRKVKVTQELK | 1 | O94868 | |
| QPQKRKPKTGILMLN | 61 | P22830 | |
| IMIKKPQKSKPGVFS | 516 | P42261 | |
| ANKKPVQLPRGMVKS | 116 | P49336 | |
| GQAKQKKRVMIPVPA | 296 | Q96EY1 | |
| NITEGKKKPTKTPQM | 171 | Q9UHW9 | |
| DHAKPIKKQMKIGPA | 141 | Q9H329 | |
| RVLEKSPGKLLVKMP | 211 | P51608 | |
| MSQSKGKKRNPGLKI | 1 | P52564 | |
| IGPKGMLKNKTRILV | 811 | P33527 | |
| EKPLVISQMGSKKKP | 86 | Q9GZR2 | |
| KNLKVKGPVRMPTKT | 46 | P60866 | |
| NGSQIKAPIPKARKM | 226 | Q9HCH5 | |
| PPIKVMTLGRILVKK | 196 | O75445 | |
| NPKMPTGEIEIKVKT | 131 | Q6PI48 | |
| KENVPPKNLAKAMKV | 41 | Q9Y6A5 | |
| PLVLPASKGKNMKTQ | 21 | Q96KN7 | |
| GKPKVKKLQLEETMP | 1221 | Q02880 | |
| KAGPVAVQVKAEKPM | 591 | Q13428 | |
| KTMDKIIRGKLALPP | 276 | Q9UBS0 | |
| QLMNGPIRKKLKIIP | 311 | Q9HB40 | |
| KNRKPVVMKIKPGIS | 126 | Q9Y227 | |
| SAPLMKKGKQREIPK | 511 | Q96T21 | |
| GLIKSPKPLMKKQAV | 26 | Q9H093 | |
| MVPISKQPKEKIQAI | 426 | O94818 | |
| PIPVMLLGVTLLKKK | 121 | P78383 | |
| MKKLQGAHLRKPVTP | 1 | Q99884 | |
| VQRPSLKMPKVDLKG | 761 | Q8IVF2 | |
| MPKVDLKSPQVDIKG | 3401 | Q8IVF2 | |
| AIPIKQGMLLKRSGK | 281 | A6NIR3 | |
| MIIVKGKKLPSDPDV | 536 | Q15111 | |
| VVKLKIPMDNKEVPG | 36 | Q7L3S4 | |
| IRPKMAKKKPTAIVN | 391 | Q70YC5 | |
| PTLQTDLLPKMKGKK | 251 | Q9BZQ8 | |
| KIMVRKPGAPVETAK | 756 | Q9UBZ9 | |
| VEMPLPKKLKSVTPV | 1851 | P12270 | |
| KIMKLLLKIKNGTPP | 496 | O75533 | |
| LLKIKNGTPPMRKAA | 501 | O75533 | |
| LPSPQMLKGKILVKG | 456 | O75038 | |
| FGRLQRIIPKIMPKK | 101 | Q7RTT4 | |
| PKKQKSVFKPRTMQG | 316 | Q9NW82 | |
| SVFKPRTMQGKKVIP | 321 | Q9NW82 | |
| SLSPVKKKKMVPGAL | 131 | Q9BXM0 | |
| KVKLLGKPVQMPSLN | 1066 | Q96MS0 | |
| KKLRVQPVQSMKPVS | 61 | Q92800 | |
| VPQSTKKMKPAIAPK | 41 | Q6ZV73 | |
| KKMQPKPSRKVDASL | 776 | Q3MJ13 | |
| VKPLKPNGIKMEKFV | 371 | Q3KQV9 | |
| LTKPMQYKVVVPKIG | 486 | Q9Y4E8 | |
| KSPPIMEVKVPVGKA | 811 | Q8TBZ2 | |
| TKKIGKKPVAKMPLR | 2286 | O95359 | |
| QLIKPDKPNGIKMEK | 366 | Q16222 | |
| KGKKTQMAEVLPSPR | 1201 | P11388 | |
| KKMPVSQKLTLVAPP | 956 | Q9NPG3 | |
| VPEDMLNKKTLPGVK | 21 | Q8N8L2 | |
| PLPVDKIIQRTKKMV | 206 | Q96KN8 | |
| VKGQEVRLEKMTPPK | 111 | Q8IWY8 | |
| PKQMKEPKSIIATKN | 821 | O60315 | |
| EGNKKDPRVPKLSKM | 456 | Q9Y6X0 | |
| SKGRKMELIQPKEPT | 361 | Q9H0E7 | |
| QIKNVLIPKMKISPK | 296 | Q8IWR1 | |
| DTVMIRPLPVKPKTK | 431 | Q9BWF2 | |
| GVPSPIMATKIPKKV | 51 | A6NNM8 | |
| QVKMKPKITRPPINV | 116 | O15146 |